Page last updated: 2024-08-17

quinoxalines and Smoking Cessation

quinoxalines has been researched along with Smoking Cessation in 632 studies

Research

Studies (632)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	221 (34.97)	29.6817
2010's	394 (62.34)	24.3611
2020's	17 (2.69)	2.80

Authors

Authors	Studies
Boezen, HM; Bos, JHJ; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B	1
Goldman, RD; Yan, T	1
Hussain, S; Le Foll, B; Mansoursadeghi-Gilan, T; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H	1
Mills, J	1
Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S	1
Cinciripini, P; Colder, C; George, TP; Hawk, LW; Mahoney, MC; Schnoll, R; Swan, GE; Tonkin, SS; Tyndale, RF	1
Alamo, A; Caci, G; Campagna, D; Caponnetto, P; Cibella, F; Di Mauro, M; Franek, E; Frittitta, L; Krysinski, A; Maglia, M; Polosa, R; Russo, C; Walicka, M	1
Humair, JP; Papachristou, C	1
Kang, DW; Lee, EK; Park, SK	1
Ashare, RL; Brandon, TH; Colder, CR; Hawk, LW; Mahoney, MC; Tiffany, ST; Tyndale, RF; Wray, JM	1
Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP	1
Eisenberg, MJ; Moiz, A	1
Aveyard, P; Farley, A; Hollands, GJ; Lindson, N; Naughton, F	1
George, TP; Kozak, K	1
Benipal, S; Bilimoria, K; Budhram, DR; Persaud, N; Wang, R; Woods, H	1
Colder, CR; Cooper, RK; Gass, JC; Hawk, LW; Lawson, SC; Mahoney, MC; Tiffany, ST; Tonkin, SS	1
Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC	1
Boezen, HM; Bos, JH; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B	1
Kress, CM; Obi, NU; Prochazka, AV	1
Brath, H; Fasching, P; Kaser, S; Tatschl, C	1
Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I	1
Brady, KT; George, MS; Gray, KM; Hartwell, KJ; Lematty, T; McRae-Clark, AL	1
Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D	1
Hviid, A; Pasternak, B; Svanström, H	2
Porwal, M; Tsoi, DT; Webster, AC	1
Tønnesen, P	3
Galaznik, A; Harnett, J; Kirchner, HL; Leader, JB; Liberman, JN; Lichtenfeld, MJ; Mastey, V; Zou, KH	1
Aubin, HJ; Berlin, I; Luquiens, A	1
Brose, LS; Stapleton, JA; West, R	1
Cunningham, CS; McMahon, LR	2
Carroll, AJ; Hong, LE; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT	2
Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S	1
Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW	1
Bawagan, J	1
Cho, B; Park, PW; Wajsbrot, D; Wang, C; Xiao, D	1
Bölcskei, PL; Davis-Wagner, P; Grundnig, J; Pommer, P	1
Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS	1
Kurioka, N	1
Behm, FM; Rose, JE	3
Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S	1
Buggy, Y; Cornelius, V; Fogg, C; Kasliwal, R; Layton, D; Shakir, SA	1
Dal Pan, GJ	1
Davis, R; Kmetova, A; Kralikova, E; Stepankova, L; West, R; Zvolska, K	1
Berg, A; Foulds, J; Franzon, M; Galaznik, A; Hughes, JR; Russ, C; Yu, CR; Zou, KH	1
Del Nogal Sáez, F; Fuentes Ponte, M; Meyer García-Sipido, E; Sanz Sanz, CL	1
Cowan, CM; Dezee, KJ; Wink, JS	1
Dhanji, AR; Hajek, P; McRobbie, H; Smith, KM	1
Cahill, K; Lancaster, T; Perera, R; Stevens, S	1
Abella, F; Baena, A; Banque, M; Bullon, R; Carreras, JM; Comino, A; Jimenez-Muro, A; Marqueta, A; Masuet-Aumatell, C; Morchon, S; Nerin, I; Pinet, C; Ramon, JM; Vilarasau, A	1
Airoldi, A; Bassi, L; Giovannelli, F; Radovanovic, D; Santus, P	1
Fagerström, KO; Jiménez-Ruiz, CA	1
Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG	1
Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF	2
Brown, J; Kotz, D; West, R	3
Cowen, PJ; Harmer, CJ; McTavish, SF; Mocking, RJ; Parsons, E; Pflanz, CP; Pringle, A; Schene, AH; Wever, SA	1
Acuña, M; Bertoglia, MP; Bustamante, P; Cavada, G; Navarrete, S; Peña, P; Suárez, C; Zagolin, M	1
Brose, L; Brown, J; Herbec, A; Raupach, T; West, R	1
Harrison-Woolrych, M; Paterson, H; Tan, M	1
Goelz, P; Gupta, T; Jain, R; Jain, V; Jhanjee, S; Mittal, S; Schnoll, RA; Wileyto, EP	1
Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD	1
Ebbert, JO; Frye, MA; Geske, JR; Lineberry, TW; Patten, CA; Prince, CA	1
Hajek, P; Hartmann-Boyce, J; Jarvis, M; Lancaster, T; Stead, LF; West, R	1
Trivedi, D	1
Hays, JT	2
Clair, C; Rigotti, NA	1
Baker, NL; Carpenter, MJ; Gray, KM; McClure, EA; Saladin, ME	1
Frohlich, J; Graham, A; McNaughton, B; Young, QR	1
Gibbons, RD; Mann, JJ	1
Ebbert, JO	2
Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C	1
Hughes, JR; Messig, MA; Russ, C	1
Boomershine, V; Haber, SL; Raney, E	1
Evins, AE; Fullerton, CA; Hoeppner, SS; Roh, S; Schoenfeld, D; Stoeckel, LE	1
Davies, NM; Gunnell, D; Martin, RM; Metcalfe, C; Thomas, KH; Windmeijer, F	2
Cappell, K; Galaznik, A; Lenhart, G; Makinson, G; Montejano, L; Zou, KH	1
Dow, WH; Rungruanghiranya, S; White, JS	1
Pezzuto, A; Spoto, C; Tonini, G; Vincenzi, B	1
Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S	1
Goutier, W; Kloeze, MB; McCreary, AC	1
Eren, A; Gecmen, C; Kalayci, A; Karabay, CY; Kirma, C; Kocabay, G	1
Davies, SP	1
Barrios, M; Cicero, A; Cristóbal, M; Jiménez-Ruiz, CA; Mayayo, M; Peña, S; Perera, L	1
Lerman, C; Perkins, KA	1
Evins, AE	1
Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P	1
Baba, Y; Kurahashi, K; Nagamine, Y; Shimizu, Y	1
Bobes, J; Diaz-Mesa, E; Elizagarate, E; Galvan, G; Garcia-Alvarez, L; Garcia-Blanco, J; Garcia-Portilla, MP; Saiz, PA; Sarramea, F	1
Cobb, NK; Graham, AL; Mays, D	1
Achtyes, ED; Ayer, D; Cather, C; Evins, AE; Goff, DC; Hoeppner, SS; Pachas, GN; Pratt, SA; Schoenfeld, DA	1
Allen, SS; Croghan, IT; Ebbert, JO; Hatsukami, DK; Hays, JT; Hurt, RD; Schroeder, DR	1
Cahill, K; Lancaster, T; Stevens, S	1
Brandon, TH; Correa, JB; Drobes, DJ; Heckman, BW; Marquinez, NS; Roetzheim, RG; Unrod, M	1
Cinciripini, PM; Karam-Hage, M	1
Cieślewicz, A; Jabłecka, A; Korzeniowska, K	1
Daughton, DM; Rennard, SI	1
Chou, MY; Hsueh, KC; Hsueh, SC; McEwen, A; Pan, LF; Tu, MS; West, R	1
Brusaferro, S; De Bacquer, D; de Velasco, J; Hoes, A; Jennings, C; Jones, J; Kotseva, K; Mead, A; Tonstad, S; Wood, D	1
Anderson, P; Johnson, M; Lockhart, I	1
Adachi, T; Inoue, T; Kato, T; Miyagawa, K; Node, K; Taguchi, I; Takeda, H; Toyoda, S; Umeda, A	1
Austin, AJ; Duka, T; Jackson, A; Rusted, J	1
Møller, AM; Thomsen, T; Villebro, N	1
Iwaoka, M; Kugiyama, K; Shimamura, H; Tsuji, T	1
Ito, H; Nakamichi, N; Nakamura, N; Nozaki, Y; Oze, I; Saka, H; Sakakibara, H; Tachibana, K; Tanaka, H; Taniguchi, C; Tokoro, A	1
Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA	2
Härmark, L; Oosterhuis, I; van Puijenbroek, E	1
Cantrell, A; Everson-Hock, E; Leaviss, J; Ren, S; Stevens, JW; Stevenson, M; Strong, M; Sullivan, W	1
Davis, C; Galaznik, A; Joshi, AV; Patel, NC; Suehs, BT; Zou, KH	1
Aitken, D; Clyde, M; Corran, B; Els, C; Pipe, A; Reid, RD; Tulloch, H	1
Arnsten, JH; Nahvi, S; Ning, Y; Richter, KP; Segal, KS	1
Sedgwick, P	3
Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P	1
de Wert, G; Horstman, K; Kotz, D; van Schayck, OC; Vuurman, E	1
Hoogsteder, PH; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W	1
Mendelsohn, CP; Richmond, RL; Zwar, NA	1
Rausch, R	1
Gonzales, D; Hajek, P; McRae, TD; Nackaerts, K; Pliamm, L; Treadow, J; Tseng, LJ	1
Arnsten, JH; Litwin, AH; Nahvi, S; Segal, KS	1
Hawk, LW; Mahoney, MC; O'Connor, RJ; Schlienz, NJ; Tiffany, ST	1
Anderson, BJ; Caviness, CM; de Dios, MA; Stein, MD	1
Caro Gutiérrez, D; Feltes Ochoa, RA; Gómez de la Fuente, E; López Estebaranz, JL; Salamanca Santamaría, FJ	1
Kmeťová, A; Králíková, E; Zvolská, K	1
Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN	1
Brar, JS; Chengappa, KN; George, TP; Hetrick, ML; Levine, MD; Perkins, KA; Schlicht, PJ; Turkin, SR	1
Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, S; Hnin, KM; Jannes, J; Koblar, SA; Litt, J; Peters, MJ; Singh, K; Smith, BJ; Veale, AJ	1
By, K; Graham, DJ; Kelman, JA; Kornegay, C; Levenson, M; MaCurdy, TE; McKean, S; Mosholder, A; Racoosin, JA; Worrall, C; Young, J	1
Baker, NL; Carpenter, MJ; Froeliger, BE; Gipson, CD; Gray, KM; Kalivas, PW; McClure, EA; Roper, AP	1
Goldberg, JF	1
Bujarski, S; Ray, LA	1
Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, SM; Javitz, HS; Kim, RB; Krasnow, R; Kwok, PY; McClure, JB; Michel, M; Nishita, D; Swan, GE; Tyndale, RF	1
Faessel, HM; Gastonguay, MR; Lee, TC; Niaura, R; Ravva, P	1
Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R	1
Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Schassburger, RL; Sved, AF; Weaver, MT	1
Cicero Guerrero, A; Cristóbal Fernández, M; Jiménez-Ruiz, CA; Mayayo Ulibarri, M; Pascual Lledó, JF; Perera López, L	1
Ditre, JW; Farris, SG; Leventhal, AM; Schmidt, NB; Zvolensky, MJ	1
Britton, J; Huang, Y; Lewis, S	1
Adams, S; Attwood, AS; McClernon, FJ; Munafò, MR; Williams, T	1
Baena, A; Masuet-Aumatell, C; Morchon, S; Ramon, JM	1
Steurer, J	1
Abe, S; Imaizumi, S; Kawachi, E; Matsuo, Y; Miura, S; Noda, K; Saku, K; Shimizu, T; Suematsu, Y; Takata, K; Tsukahara, H; Uehara, Y; Yahiro, E; Zhang, B	1
Barra, NG; De Long, NE; Hardy, DB; Holloway, AC	1
Barkema, HW; Clement, F; Coward, S; Ghosh, S; Heitman, SJ; Kaplan, GG; Leung, YP; Negron, M; Panaccione, R; Seow, C	1
Caduff-Janosa, P; Savage, RL; Zekarias, A	1
Arbab-Zadeh, A; Garg, J; Krishnamoorthy, P; Lavie, CJ; Lichstein, E; Sharma, A; Sochor, O; Thakar, S	1
Ballbè, M; Cabezas, C; Fernández, E; Gual, A; Martínez, C; Riccobene, A; Saltó, E; Valverde, A	1
Rigotti, NA	2
Cornwall, D; Dhanji, AR; Hajek, P; McRobbie, H; Myers Smith, K; Phillips, A	1
Chan, S; Cheng, K; He, Y; Jiang, B; Lam, T; Liu, Q; Wu, L; Zhang, L; Zhou, C; Zuo, F	1
Andreas, S; Reinhardt, C	1
Dutro, MP; Ebbert, JO; Hughes, JR; McRae, TD; Park, PW; Rennard, SI; Russ, C; Treadow, J; West, RJ; Yu, CR	1
Potter, AS	1
Baker, NL; Carpenter, MJ; Gray, KM; Hartwell, KJ; McClure, EA; Ramakrishnan, V; Saladin, ME	1
Borland, R; Brady, K; Carpenter, MJ; Cummings, KM; Fong, GT; Hartwell, K; Hyland, A; Kasza, KA; McKee, SA; Smith, PH	1
Gorelick, DA	1
Nau, JY	2
Higuchi, S; Kimura, M; Maesato, H; Matsushita, S; Mizukami, T; Nakayama, H; Sakuma, H; Takimura, T; Yokoyama, A; Yoneda, J; Yoshimura, A	1
Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F	1
Tofler, IR	1
Brar, JS; Chengappa, KN; George, TP; Levine, MD; Perkins, KA; Turkin, SR	1
Fazel, S; Gumpert, CH; Lichtenstein, P; Molero, Y; Zetterqvist, J	1
Clark, CB; Cropsey, KL; Hendricks, PS	1
Block, CA; O'Rourke, DJ; Robey, RB	1
Ebbert, JO; Hughes, JR; West, RJ	1
Fagerstrom, K	1
Furberg, RD; Krebs, P; Pham, H; Shelley, D; Sherman, SE; Tseng, TY; Wolfe, H; Wong, S	1
Barras, D	1
Burkholder, GA; Clark, CB; Cropsey, KL; Jardin, BF; Raper, JL; Saag, MS	1
He, Y; Sun, S; Wu, L; Zeng, J	1
Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö	1
Azuma, J; Fujio, Y; Hirohashi, K; Iguchi, T; Kobayashi, M; Maeda, M; Morimura, M; Norioka, N; Shimada, K; Shuto, T; Takemoto, Y; Yoshiyama, M	1
Koilpillai, P; Lancaster, T; Stead, LF	1
Primack, BA	1
Croghan, E; Kiparoglou, V; Robinson, H; van Woerden, HC; Walker, NJ; Yang, Y	1
Billing, CB; Hays, JT; Jorenby, DE; Leone, FT; Niaura, R; Pappas, JE; Reeves, KR; Williams, KE	1
Popkin, MK	1
Bölcskei, PL; Walden, K	1
Kuehn, BM	6
Rankin, KV	1
Ochoa, EL	1
Nelson, R; Pumariega, AJ; Rotenberg, L	1
Fatemi, SH	1
Miller, WA; Song, W	1
Chawla, PS; Kochar, MS	1
Kapoor, S	1
Fashner, J; Mayo, HG; Rao, S; Shah, ZH	1
Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D	1
Cahill, K; Lancaster, T; Stead, LF	5
Burstein, AH; Clark, DJ; Faessel, HM; Rohrbacher, KD; Troutman, MD; Willavize, SA	1
Aveyard, P	2
Rose, JE	2
Bhowmik, A; Hillman, T; Rajakulasingam, K	1
Evins, AE; Goff, DC	1
Chitkara, R; Krishna, G; Mohanasundaram, UM	1
Nadeem, SS; Pirmoradi, P; Roshan, S	1
Ferguson, SG; Shiffman, S	1
McIntyre, RS	1
Freeman, A; Juncos, JL; Sullivan, KL; Zesiewicz, TA	1
Soares, C	1
Frøynes, W; Schjøtt, J	1
Delva, NJ	1
Reus, VI; Smith, BJ	1
Tutka, P	1
Frey, JM; Gur, RC; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, KA; Siegel, S; Strasser, AA	1
Bader, P; McDonald, P; Selby, P	1
Hering, T	4
Schunack, W	1
Brace, V; Danielian, P; Rore, C; Williams, D	1
Bird, ML; Vesta, KS	1
Ebbert, JO; Hays, JT	2
Catz, SL; Deprey, TM; Halperin, AC; Jack, LM; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Sillman, JS; Smetana, GW	1
Lyon, GJ	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G	1
Galanti, LM	1
Boyd, JW; Lasser, KE	1
Peiffer, G	1
Carrozzi, L; Pistelli, F; Viegi, G	1
Ericson, M; Löf, E; Söderpalm, B; Stomberg, R	1
Schroeder, SA	1
McEwen, A; West, R	1
Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M	1
Einarson, A; Riordan, S	1
Caron, J; Duparc, A; Gosset, P; Lasek, A; Modiano, P	1
Florek, E; Piekoszewski, W	1
Chan, KP; Davies, S; Garza, D; Pothirat, C; Wang, C; Xiao, D	1
Cocores, JA; Gold, MS	1
Spirling, LI; Stapleton, JA; Sutherland, G	1
Cantrell, MA; Geraets, D	1
Collier, R	1
Groman, E; Homaier, I; Lichtenschopf, A; Tschabitscher, P	1
Goldstein, I; Korda, JB; Pfaus, JG	1
Cahill, K; Lancaster, T; Stead, L	2
Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Cirimele, V; Evans, J; Kintz, P; Villain, M	1
Arora, G; Jain, M; Talwar, A	1
Faessel, H; Ravva, P; Williams, K	1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR; Sood, A	1
Arroyo, O; Brosa Riestra, M; Fernández de Bobadilla Osorio, J; Sánchez-Maestre, C; Sanz de Burgoa, V; Wilson, K	1
Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR; Whiteley, LB	1
Burke, MV; Ebbert, JO; Hays, JT; Hurt, RD	1
Fukuda, T; Igarashi, A; Takuma, H; Tsutani, K	1
Bergstrom, T; Guo, Y; Lv, Y; Xiao, Y; Zhang, X	1
Anghelescu, I	1
Silva, RR	1
Balvanz, TM; Magallon, HE; Mambourg, SE; Pham, RH; Purvis, TL	1
Dugan, SE; Garrison, GD	1
Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P	1
Laine, P; Lindeman, S; Marttila, J	1
Diehl, A; Grosshans, M; Hermann, D; Mann, K; Mutschler, J	1
Stapleton, J	1
Laniado-Laborín, R	2
Bruguera, E; Ramon, JM	1
George, TP; Lising-Enriquez, K	1
Kasliwal, R; Shakir, SA; Wilton, LV	1
Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL	1
Bybee, K; Jones, PG; Lee, JH; O'Keefe, JH	1
Fegan, PG; Wood, SE	1
Heimlich, L; Steinberg, ML; Williams, JM	1
Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K	1
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T	1
Keiding, H	1
Bolin, K; Mörk, AC; Wilson, K	1
DiPaula, BA; Thomas, MD	1
Berlin, I; Hering, T; Jiménez-Ruiz, C	1
Franck, AJ; Sliter, LR	1
Arteaga, C; Hajek, P; Russ, C; Tonstad, S; Tønnesen, P	1
Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ	1
Abou-Zeid, E; Keyrouz, SG; Rudnicki, SA	1
Elia, D; Giucastro, G; Marangio, E; Mariano, ME; Olivieri, D; Scarascia, A; Tzani, P	1
Maritz, GS	1
Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J	1
Kranzler, HR; Oncken, CA	1
Frey, J; Gur, R; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, K; Siegel, S; Strasser, AA	1
Tonstad, S	2
Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L	1
Hind, D; Kenjegalieva, K; Peters, J; Tappenden, P	1
Clark, MM; Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Sood, A	1
Lavigne, JE	1
Batra, A; Friederich, HM	1
Faessel, HM; Gastonguay, MR; Ravva, P; Tensfeldt, TG	1
Cantrell, FL; Clark, AK; Clark, RF; Kreshak, AA; Ly, BT	1
Mafé, C; Tornero, C	1
Hao, W; Tan, L; Tang, Q	1
Booij, J; Crunelle, CL; Miller, ML; van den Brink, W	1
Richins, C	1
Burke, MV; Ebbert, JO; Hays, J; Wyatt, KD; Zirakzadeh, A	1
Ockene, I; Salmoirago-Blotcher, E	1
Arteaga, C; Benowitz, NL; Garza, D; Pipe, AL; Rigotti, NA; Tonstad, S	1
Jormanainen, V; Kotomäki, T; Linden, K; Linna, M; Sintonen, H; Wilson, K	1
Corelli, RL; Hudmon, KS; Prokhorov, AV	1
Anthenelli, RM; Arteaga, C; Heffner, JL; Lee, TC	1
Faessel, HM; French, JL; Gastonguay, MR; Ravva, P; Tensfeldt, TG	1
Keating, GM; Lyseng-Williamson, KA	2
Blak, BT; Hards, M; Maguire, A; Metcalfe, M; Wilson, K	1
Noda, K; Saku, K; Tsukahara, H	1
Mambourg, SE; Nelson, LA; Purvis, TL	1
Blumberger, D; George, TP; Ismail, Z; Syms, J	1
Allorge, D; Broly, F; Colombel, JF; Cortot, A; Jouet, JP; Torres, J; Tremblay, L	1
Benowitz, NL; Hukkanen, J; Ukkola, O	1
Gur, RC; Lerman, C; Loughead, J; Ray, R; Ruparel, K; Sanborn, P; Siegel, S; Wileyto, EP	1
Drach, L; Fox, V; Holbert, T; Maher, J; Saddler, LC; Schubert, S	1
Davies, S; Flammer, M; Hughes, J; Russ, C; Tonstad, S	1
Fonte, CA; Lerman, C; Mercincavage, M; Perkins, KA	1
Bertrand, D; Bertrand, S; Coe, JW; Cremers, T; de Vries, M; Hurst, RS; Mather, RJ; O'Neill, BT; Rollema, H; Shrikhande, A; Tingley, FD; Tseng, E; Wang, EQ; Ward, KM; Williams, KE	1
Costa, E; Davis, JM; Guidotti, A; Lajtha, A; Maloku, E; Sershen, H; Smith, RC; Zhubi, A	1
Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, T; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Hayashi, K; Hori, H; Hoshuyama, T; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R	1
Beck, HN; Biazzo, LL; Campbell, SL; Froshaug, DB; Harwell, TS; Haugland, C; Helgerson, SD	1
Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Baran, XY; Docherty, JP	1
Hays, JT; Lawrence, D; Lee, TC; Leischow, SJ	1
Hizue, M; Ishibashi, T; Nomura, S	1
Bhat, A; Crain, D	1
Chengappa, KN; Fonte, CA; Jain, A; Lerman, C; Mercincavage, M; Perkins, KA; Stitzer, ML	1
Rollema, H; Tonstad, S	1
Fujimoto, Y; Hasunuma, T; Kikkawa, H; Maruyama, N	1
Ioannides-Demos, LL; McNeil, JJ; Piccenna, L	1
Ashton, J; Harrison-Woolrych, M	2
Lund, KE; McNeill, A; Scheffels, J	1
Herman, AI; Sofuoglu, M	1
Furberg, CD; Glenmullen, J; Moore, TJ	1
Cho, HJ; Davies, S; Fagerström, K; Lee, TC; Ma, W; Nakamura, M; Russ, C; Tsai, ST; Wang, C	1
Ruff, P	1
Zeller, A	1
von Garnier, C	1
Croghan, IT; Ebbert, JO; North, F; Schroeder, DR	1
Pelle, AJ; Smolderen, KG	1
Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC	1
Garelik, DA	1
Hays, JT; Lawrence, D; Lee, TC; Ma, W; Rennard, S; Tashkin, DP	1
Chen, CI; Harnett, J; Mastey, V; Patel, BV; Zeng, F; Zou, KH	2
Baker, CL; Bushmakin, AG; Cappelleri, JC; Croghan, IT; Hays, JT	1
Choi, BW; Choi, JC; Jeon, EJ; Jung, JW; Kim, DK; Kim, JG; Kim, JY; Park, IW; Shin, JW; Yang, SY	1
Tavares, AR; Volpe, FM	1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR	1
Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM	1
Anderson, KD; Campbell, AR	1
Johnson, TS	1
Agboola, S; Coleman, T; Leonardi-Bee, J; McEwen, A; McNeill, A; Taylor, M	1
Burstein, AH; Faessel, HM; Obach, RS; Ravva, P; Rollema, H; Williams, KE	1
Blendy, JA; Castellano, LM; Turner, JR	1
Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G	1
Asano, A; Hasegawa, M; Katsura, H; Kiguchi, T; Nagai, A; Nozu, T; Onizawa, S; Saiki, K; Taniguchi, H	1
Balmford, J; Borland, R; Cummings, KM; Hammond, D	1
Giwa, TA; MacSuibhne, S; McCauley, MD	1
Childress, AR; Cruz, J; Detre, JA; Franklin, T; Goldman, M; Hazan, R; Li, Y; O'Brien, CP; Suh, JJ; Wang, Z	1
Walsh, RA	1
Fucito, LM; O'Malley, SS; Romano, DM; Tek, E; Toll, BA; Wu, R	1
López, AR; Vasco, PG	1
Allan, GM; Els, C; Ivers, N	1
Weinsier, ST	1
Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C	1
Crespel, A; Gelisse, P; Serafini, A; Velizara, R	1
Boudrez, H; Gratziou, C; Messig, M; Metcalfe, M	1
Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ	1
Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, A; McNeill, A; Rivard, C	1
Bush, T; Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Enea, D; Ferketich, AK; Grassi, MC; Lu, B; Nencini, P; Pasquariello, S	1
Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, T; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Grief, SN	1
Buchanan, RW; Buchholz, A; Coffay, A; Kelly, DL; Liu, F; McMahon, RP; Weiner, E	1
Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A	1
Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L	1
Guwanardane, N; Hussain, S; Kayne, E; Petrides, G	1
Kelsall, D	1
Bangpattanasiri, K; Rujiraruchana, K; Sangsayunh, P	1
Caro, JJ; Davies, S; Ishak, KJ; Kinter, ET; Marton, JP; Ward, AJ; Willke, RJ; Xenakis, JG	1
Kotz, D; van Schayck, OCP	1
Francois, D; Kotbi, N; Odom, A	1
Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Nazir, N; Nollen, NL; Owen, A; Pankey, S; Thompson, N	1
Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Severson, HH	1
Gur, RC; Lerman, C; Loughead, J; O'Donnell, GP; Ray, R; Ruparel, K; Senecal, N; Siegel, S; Wileyto, EP	1
Davies, D; Dresler, C; Hilgenberg, J; Japuntich, S; Lanuti, M; Pandiscio, J; Park, ER; Rigotti, NA; Temel, J	1
Dhanji, AR; Hajek, P; McRobbie, HJ; Myers, KE; Stapleton, J	1
Simon, JA	1
Aubin, HJ; Karila, L; Reynaud, M	1
Fidler, JA; Kotz, D; West, R	2
O'Malley, SS	1
Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M	1
Coleman, T; Lewis, S; McNeill, A; Szatkowski, L	1
Beebe, LA; Choi, WS; Cully, L; Daley, CM; Faseru, B; Greiner, AK; Kaur, B; Shireman, TI; Talawyma, M; Yeh, HW	1
Bergen, AW; Catz, SL; Conti, DV; Deprey, M; Hinds, DA; Jack, LM; Javitz, HS; McAfee, T; McClure, JB; Michel, M; Richards, J; Stokowksi, RP; Swan, GE; Wessel, J; Zbikowski, SM	1
Lawrence, D; Lee, TC; Marton, JP; Rennard, S; Tashkin, DP; Taylor Hays, J	1
Abreu, P; Bolliger, CT; Chopra, P; Correia, EA; Issa, JS; Park, PW; Posadas-Valay, R; Safwat, T	1
Chen, MC; Jeang, SY; Liu, ME; Peng, SL; Tsai, SJ; Tsai, YL; Wu, SL; Yang, ST	1
Foulds, J; Gandhi, KK; Steinberg, MB; Steinberg, ML; Ulpe, R; Williams, JM	1
Belcon, AL	1
Bigman, C; Cappella, J; Leone, F; Lerman, C; Patterson, F; Pinto, A; Schnoll, RA; Wileyto, EP	1
Carlini, SV; Dutra, SJ; Evins, AE; Pizzagalli, DA; Stoeckel, LE	1
Marti, J	1
Stevens, KE; Wildeboer-Andrud, KM	1
Carpenter, MJ; Gray, KM; Klintworth, EM; Lewis, AL; Upadhyaya, HP	1
Jones, DL; Rankin, KV	1
Carson, JL; Greenhaus, S; Randall, J; Richardson, DL; Schmelzer, AC; Steinberg, MB	1
Casiano, EM; Claveria, AM; Escoto, L; Park, PW	1
Annemans, L; Diaz Cerezo, S; Hettle, R; Ines, M; Lopez de Sa, E; Marbaix, S; Prignot, J; Santoni, L; Wilson, K	1
Arteaga, CE; Hughes, JR; Rennard, SI; Russ, CI	1
Barendregt, JJ; Higashi, H	1
Kadokura, Y; Kano, M; Kushihashi, Y; Saito, H; Shino, M; Suzaki, H; Suzuki, M; Takiguchi, S; Yamada, Y	1
Ashare, RL; McKee, SA	1
Leung, LK; Patafio, FM; Rosser, WW	1
Baker, TB; Fiore, MC	1
Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Sved, AF; Weaver, MT	1
Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R	1
Cohen, J; Cui, Q; Elston, D; McFarland, N; McIvor, A; Quan, C; Robinson, L; Smaill, F; Smieja, M; Thabane, L; Zeidler, J	1
Lin, KW	1
Ansermot, N; Choong, E; Cornuz, J; Dobrinas, M; Eap, CB; Noetzli, M	1
Lock, K; Murphy, D; Riesco, JA; Wilson, K	1
Dhelaria, RK; Rothberg, M	1
Cho, DM; Jung, DU; Jung, SS; Kang, JW; Kelly, DL; Kim, SD; Kong, BG; Lee, JH; Lee, SW; McMahon, RP; Oh, MK; Seo, YS; Shim, JC	1
Benowitz, NL; Bierut, LJ; Conti, DV; Kaprio, J; King, DP; Lerman, C; Paciga, S; Park, PW; Pickering, E	1
Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S	1
Arteaga, C; Cinciripini, PM; Hughes, J; Kralikova, E; Raupach, T; Rennard, S; Russ, C; St Aubin, LB	1
Browning, KK; Ferketich, AK; Hall, N; King, M; Otterson, GA; Wewers, ME	1
Saito, Y; Takami, T	1
Bhindi, R; Kozor, R	1
Fidler, J; Kotz, D; West, R	1
Ashare, RL; Cummings, KM; Gass, JC; Hawk, LW; Lohnes, SF; Mahoney, MC; Rhodes, JD; Schlienz, NJ; Tiffany, ST	1
Ashton, J; Harrison-Woolrych, M; Maggo, S; Savage, R; Tan, M	1
Forcen, FE; Martinez, FL; Moya, AM	1
Lockhart, I; Mardle, T; Merrett, S; Percival, F; Wright, J	1
Coleman, T; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L	1
Heydari, G; Masjedi, MR; Tafti, SF; Talischi, F	1
Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN	1
Coleman, CI; Mahmoudi, M; Sobieraj, DM	1
Aveyard, P; Farley, AC; Hajek, P; Lycett, D	1
Härmark, L; Harrison-Woolrych, M; Maggo, S; Tan, M; van Grootheest, K	1
Bechara, A; McNutt, A; Tranel, D	1
Bai, CX; Jin, WT; Pan, J; Wang, XD; Zhang, J	1
Schuurmans, MM; Zellweger, JP	1
Cicero Guerrero, A; Cristobal Fernández, M; Jiménez Ruiz, CA; Lopez Gonzalez, G; Mayayo Ulibarri, M; Ramos Pinedo, A	1
Ahluwalia, JS; Benowitz, NL; Berg, CJ; Buchanan, TS; Choi, WS; Cox, LS; Jacob, P; Nazir, N; Nollen, NL; Yturralde, O; Yu, L	1
Anderson, BJ; Audet, DA; de Dios, MA; Stanton, C; Stein, M	1
Cuesta, G; Lovato, P; Lutz, MA	2
Azar, MR; Cohen, A; Fox, BS; George, O; Goeders, NE; Koob, GF	1
Goldstein, AO; Kistler, CE	1
Fagerström, K; Foulds, J; Russ, C; Yu, CR; Yunis, C	1
Al Hossaini, AM; Kassem, MG	1
Gass, JC; Hawk, LW; Mahoney, MC; Tiffany, ST; Wray, JM	1
Christalla, P; Dewenter, M; El-Armouche, A	1
Ashare, RL; Hawk, LW; Mahoney, MC; Rhodes, JD; Schlienz, NJ	1
Etter, JF; Schneider, NG	1
Larzelere, MM; Williams, DE	1
Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH	1
Bordia, T; Chin, M; Hrachova, M; McIntosh, JM; Quik, M	1
Gallagher, T; Haseler, CA; Rucktooa, P; Sixma, TK; Smit, AB; van Elk, R	1
Johnson, MW; McClure, EA; Stitzer, ML; Vandrey, RG	1
Browning, KK; Diaz, P; Ferketich, AK; Koletar, SL; Lu, B; Reynolds, NR; Wewers, ME	1
Bambha, K; Sprague, D	1
Carter, V; Mishagina, N; Paradis, PE; Raymond, V	1
Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ	1
Anthenelli, RM; George, TP; Morris, CD; Thompson, JR; Treadow, J; Williams, JM; Yunis, C	1
Bradley-Ewing, A; Catley, D; Ellerbeck, E; Goggin, K; Harris, KJ; Liston, R; Malomo, D; Patten, C; Resnicow, K; Richter, K; Williams, K	1
Dhelaria, RK; Friderici, J; Gupta, E; Khan, C; Rothberg, MB; Wu, K	1
Ju, W; Jung, HS; Kim, H; Myung, SK; Oh, SW; Park, CH; Seo, H	1
Coster, TS; Graham, DJ; Meyer, TE; Moeny, D; Mosholder, AD; Ouellet-Hellstrom, RP; Taylor, LG; Williams, JR; Xie, S	1
Athanasakis, K; Igoumenidis, M; Karampli, E; Kyriopoulos, J; Sykara, G; Vitsou, E	1
Ebbert, JO; Lockhart, I; Mills, EJ; Puhan, M; Thorlund, K; Wu, P	1
Duaso, M; Duncan, D	1
Abrishami, A; Chapman, KR; Chung, F; Friedman, Z; Selby, P; Wong, J; Yang, Y; Zaki, A	1
Bansal-Travers, M; Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, AJ; Kasza, KA; McNeill, AD	1
Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK	1
Cerimele, JM; Durango, A	1
Andreas, S; Chenot, JF; Diebold, R; Mann, K; Peachey, S	1
Jao, NC; Karelitz, JL; Perkins, KA	1
Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, SJ; Jannes, J; Koblar, SA; Labiszewski, NA; Litt, J; Peters, MJ; Smith, BJ; Veale, AJ	1
Argo, T; Cantrell, M; Haak, L; Janney, L	1
Mikkelsen, K; Tønnesen, P	1
Brown, VL; Cinciripini, PM; Cui, Y; Dani, JA; Engelmann, JM; Karam-Hage, M; Kosten, TR; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW	1
Cesario, A; Granone, P; Lococo, F; Petracca-Ciavarella, L; Russo, P	1
Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D	1
Abe, TO; Issa, JS; Moura, S; Pereira, AC; Santos, PC	1
Dautzenberg, B	1
Harrison-Woolrych, M	1
Caudill, C; Dumire, W; Lewis, A; Morgan, SK	1
Baker, AL; Castle, D; Filia, SL; Harris, D; Pirola-Merlo, AJ; Richmond, R	1
Colivicchi, F; Imperoli, G; Mocini, D; Santini, M; Strano, S; Uguccioni, M	1
Brauer, R; Fahim, RE; Hoogsteder, PH; Kalnik, MW; Kessler, PD; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W	1
Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP	1
Lancaster, T; Stead, LF	1
Borland, R; Cummings, KM; Fong, GT; Harrison, EL; Hyland, A; Kahler, CW; McKee, SA; Young-Wolff, KC	1
Camarelles Guillem, F; Clemente Jiménez, L; Dalmau González-Gallarza, R; Díaz-Maroto Muñoz, JL; Lozano Polo, A; Pinet Ogué, MC	1
Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF	1
Ahmed, AI; Ali, AN; Burger, DM; Härmark, LV; Kramers, C; Verhoeven, WM	1
Bujarski, S; Krull, JL; Lunny, K; Miotto, K; Moallem, N; Ray, LA	1
Arnsten, JH; Bernstein, SL; Nahvi, S; Richter, KP; Wu, B	1
Enger, C; Gately, R; Mo, J; Petronis, KR; Seeger, JD; Younus, M	1
Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C	1
Arnold, EP; Brooks, PR; Chambers, LK; Coe, JW; Davis, TI; Fox, CB; Heym, JH; Huang, J; Lebel, LA; Lu, Y; Mansbach, RS; O'Neill, BT; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Shrikhande, A; Tingley, FD; Vetelino, MG; Wirtz, MC	1
Baker, CL; Bushmakin, AG; Cappelleri, JC; Gilbert, DG; Merikle, E; Olufade, AO	2
Camarelles Guillem, F	1
Corelli, RL; Hudmon, KS	1
Foulds, J	1
Azoulay, S; Billing, CB; Gong, J; Gonzales, D; Nides, M; Oncken, C; Reeves, KR; Rennard, SI; Watsky, EJ; Williams, KE	1
Azoulay, S; Billing, CB; Gong, J; Hays, JT; Jorenby, DE; Reeves, KR; Rigotti, NA; Watsky, EJ; Williams, KE	1
Billing, CB; Hajek, P; Reeves, KR; Tonstad, S; Tønnesen, P; Williams, KE	1
Johnson, KC; Klesges, RC; Somes, G	1
Jones, C; Kirkpatrick, P; Niaura, R	1
Keating, GM; Siddiqui, MA	1
Burstein, AH; Clark, DJ; Faessel, HM; Fullerton, T	1
Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M	1
Schroeder, SA; Sox, HC	1
Dervaux, A; Kanit, M; Laqueille, X	1
Dimoulas, P; Mills, EJ; Wilson, K; Wu, P	1
Chambers, LK; Coe, JW; Glowa, J; Hurst, RS; Lebel, LA; Lu, Y; Mansbach, RS; Mather, RJ; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Tingley, FD; Williams, KE	1
Králíková, E	1
Kyle, JA; Zierler-Brown, SL	1
Siu, EC; Tyndale, RF	1
Blázovics, A	1
Coe, JW; Faessel, H; Obach, RS; Reeves, K; Reus, VI; Rollema, H; Watsky, E	1
Gonzales, D; Jorenby, DE; Reeves, KR; Rennard, SI	1
Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R	1
Frishman, WH	1
Evans, SE; Leischow, S; Nides, M; Sarna, L	1
Oberpichler-Schwenk, H	1
Martini, B	1
Billing, CB; Gong, J; Pennington, AM; Reeves, KR; Williams, KE	1
Brixner, D; Dirani, R; Jackson, KC; Nahoopii, R; Said, Q	1
Vandemergel, X	1
Crane, R	1
Duh, D; Macken, E	1
Pipe, AL; Quinlan, B; Reid, RD; Riley, DL	1
Chambers, LK; Coe, JW; Hurst, RS; Rollema, H; Stahl, SM; Williams, KE	1
Garwood, CL; Potts, LA	1
Tobin, ML	1
Anthenelli, RM	1
Oehlke, KJ	1
Miller, MC	1
Kohen, I; Kremen, N	1
Freedman, R	1
Glover, ED; Rath, JM	1
Billing, CB; Cheng, HS; Cho, HJ; Hsueh, KC; Kim, CH; Tsai, ST; Williams, KE	1
Fujimoto, Y; Ishibashi, T; Maruyama, N; Nakamura, M; Oshima, A; Reeves, KR	1
Croghan, E	1
Moorman, KL; Whitley, HP	1
Coffay, AO	1
O'Brien, CP	3
Lerman, C; Patterson, F; Schnoll, RA	1
Taéron, C	1
Brayman, TG; Burstein, AH; Clark, DJ; Faessel, HM; Grover, GS; O'Gorman, M; Obach, RS; Walsky, RL; Willavize, SA	1
Stack, NM	1
Burstein, AH; Clark, DJ; de Morais, SM; Faessel, HM; Feng, B; Obach, RS	1
Doggrell, SA	1
Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P	1
Milbrandt, A; Ratcliffe, M; Smith, R; Spirling, LI; Stapleton, JA; Sutherland, G; Watson, L	1
Cohen, AF; Dubois, EA; van Bronswijk, H; Zitman, FG	1
Andrews, JO; Bennett, SM; Heath, JH	1
Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R	1
Billing, CB; Gong, J; Pennington, AM; Reeves, KR; Spangler, JG; Williams, KE	1
Cooley, ME; Murphy, M; Sarna, L; Sipples, RL	1
Dougherty, PL	1
Aubin, HJ; Billing, CB; Bobak, A; Britton, JR; Gong, J; Oncken, C; Reeves, KR; Williams, KE	1
Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M	1
Bolin, K; Lindgren, B; Mörk, AC; Willers, S	1
Benowitz, NL	1
Stapleton, JA	1
Ebbert, JO; Hays, JT; Sood, A	1
Kristensen, PL; Pedersen-Bjergaard, U; Thorsteinsson, B	1
Asch, DA; Heitjan, DF; Lerman, C; Patterson, F; Ray, R; Rukstalis, M	1
Tyndale, R	1
Wonnacott, S	1
Dirani, R; Halpern, MT; Schmier, JK	1
Czogała, J; Goniewicz, ML; Koszowski, B; Sobczak, A	1
Gould, TJ; Gulick, D	1
Perno Goldie, M	1
Crawford, JT; Goldenberg, RL; Tolosa, JE	1
Brees, DJ; Cai, JH; Elwell, MR; Finkelstein, MB; Jakowski, AB; Sands, SB; Shen, AC; Tingley, FD	1
Baker, C; Boler, A; Howard, P; Knight, C	1

Reviews

139 review(s) available for quinoxalines and Smoking Cessation

Article	Year
Interventions to increase adherence to medications for tobacco dependence. The Cochrane database of systematic reviews, 2019, 08-16, Volume: 8 Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder	2019
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:5 Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2020
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review. Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:7 Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2021
[Smoking, alcohol and diabetes (Update 2019)]. Wiener klinische Wochenschrift, 2019, Volume: 131, Issue:Suppl 1 Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2019
[Drugs used to treat nicotine addiction]. Przeglad lekarski, 2012, Volume: 69, Issue:10 Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult	2012
Interventions for smoking cessation and reduction in individuals with schizophrenia. The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline	2013
Smoking cessation and COPD. European respiratory review : an official journal of the European Respiratory Society, 2013, Mar-01, Volume: 22, Issue:127 Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. British journal of clinical pharmacology, 2014, Volume: 77, Issue:2 Topics: Adolescent; Benzazepines; Bupropion; Counseling; Drug Design; Female; Humans; Molecular Sequence Data; Pregnancy; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2014
[Current approaches to smoking cessation]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:17 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cooperative Behavior; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Germany; Health Priorities; Health Surveys; Humans; Interdisciplinary Communication; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult	2013
[On oral medications, especially varenicline]. Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:3 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Pharmacological interventions for smoking cessation: an overview and network meta-analysis. The Cochrane database of systematic reviews, 2013, May-31, Issue:5 Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
Varenicline and evaluated outcomes in smoking cessation programmes. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 79, Issue:1 Topics: Benzazepines; Clinical Trials as Topic; Humans; Lung; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2013
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 79, Issue:1 Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction (Abingdon, England), 2014, Volume: 109, Issue:1 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Medication Adherence; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2014
Relapse prevention interventions for smoking cessation. The Cochrane database of systematic reviews, 2013, Aug-20, Issue:8 Topics: Behavior Therapy; Benzazepines; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline	2013
Cochrane review summary: Pharmacological interventions for promoting smoking cessation during pregnancy. Primary health care research & development, 2013, Volume: 14, Issue:4 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Birth Weight; Bupropion; Female; Humans; Infant, Newborn; Medication Adherence; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
Managing tobacco use: the neglected cardiovascular disease risk factor. European heart journal, 2013, Volume: 34, Issue:42 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Counseling; Female; Health Promotion; Humans; Male; Nicotinic Agonists; Physician's Role; Quinoxalines; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
Safety of varenicline in patients with cardiovascular disease. Journal of pharmacy practice, 2014, Volume: 27, Issue:1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2014
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology, 2014, Volume: 231, Issue:1 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Cross-Over Studies; Drug Evaluation, Preclinical; Feasibility Studies; Humans; Quinoxalines; Research Design; Smoking Cessation; Validation Studies as Topic; Varenicline	2014
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation, 2014, Jan-07, Volume: 129, Issue:1 Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline	2014
Smoking cessation. Clinics in chest medicine, 2014, Volume: 35, Issue:1 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2014
Interventions for preoperative smoking cessation. The Cochrane database of systematic reviews, 2014, Mar-27, Issue:3 Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Postoperative Complications; Preoperative Care; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2014
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Health technology assessment (Winchester, England), 2014, Volume: 18, Issue:33 Topics: Adult; Aged; Alkaloids; Azocines; Benzazepines; Cost-Benefit Analysis; Humans; Middle Aged; Nicotinic Agonists; Quality-Adjusted Life Years; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; State Medicine; United Kingdom; Varenicline	2014
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction (Abingdon, England), 2014, Volume: 109, Issue:9 Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; School Health Services; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Is it safe to use smoking cessation therapeutics during pregnancy? Expert opinion on drug safety, 2014, Volume: 13, Issue:12 Topics: Animals; Benzazepines; Bupropion; Female; Humans; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2014
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies. Current cardiology reports, 2015, Volume: 17, Issue:1 Topics: Benzazepines; Bupropion; Chest Pain; Dose-Response Relationship, Drug; Humans; Hypertension; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Seizures; Smoking Cessation; Smoking Prevention; Tachycardia; Varenicline	2015
[Smoking cessation--what's new?]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:3 Topics: Benzazepines; Combined Modality Therapy; Electronic Nicotine Delivery Systems; Humans; Motivational Interviewing; Nicotinic Agonists; Patient Compliance; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Smoking Cessation; Varenicline	2015
Interventions to increase adherence to medications for tobacco dependence. The Cochrane database of systematic reviews, 2015, Feb-23, Issue:2 Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2015
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled. International journal of environmental research and public health, 2015, Aug-25, Volume: 12, Issue:9 Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2015
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. The Cochrane database of systematic reviews, 2015, Oct-12, Issue:10 Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2015
[The ABC of smoking cessation]. Medizinische Monatsschrift fur Pharmazeuten, 2008, Volume: 31, Issue:5 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2008
What's new in clinical pharmacology and therapeutics. WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2 Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines	2008
Varenicline and its role in smoking cessation. Preventive cardiology, 2008,Summer, Volume: 11, Issue:3 Topics: Benzazepines; Humans; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2008
Which drug to be used in smoking cessation? Polskie Archiwum Medycyny Wewnetrznej, 2008, Volume: 118, Issue:6 Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2008
Clinical inquiries. What are the most effective ways you can help patients stop smoking? The Journal of family practice, 2008, Volume: 57, Issue:7 Topics: Benzazepines; Counseling; Family Practice; Health Promotion; Humans; Medical History Taking; Office Visits; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline	2008
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Jul-15, Volume: 179, Issue:2 Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2008, Jul-16, Issue:3 Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2008
Smoking cessation therapy with varenicline. International journal of chronic obstructive pulmonary disease, 2008, Volume: 3, Issue:2 Topics: Benzazepines; Humans; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2008
The relevance and treatment of cue-induced cravings in tobacco dependence. Journal of substance abuse treatment, 2009, Volume: 36, Issue:3 Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2009
Drugs for tobacco dependence. Treatment guidelines from the Medical Letter, 2008, Volume: 6, Issue:73 Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2008
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. International journal of clinical practice, 2008, Volume: 62, Issue:11 Topics: Benzazepines; Combined Modality Therapy; Complementary Therapies; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Psychotherapy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation. Expert opinion on investigational drugs, 2008, Volume: 17, Issue:10 Topics: Alkaloids; Animals; Azocines; Benzazepines; Clinical Trials as Topic; Dopamine; Humans; Nicotinic Agonists; Quinolizines; Quinoxalines; Smoking Cessation; Varenicline	2008
[Modern medical support for smoking cessation]. Der Internist, 2009, Volume: 50, Issue:1 Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline	2009
[Not smoking, essential for healthy lungs]. Pharmazie in unserer Zeit, 2008, Volume: 37, Issue:6 Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline	2008
Smoking cessation in pregnancy. Expert opinion on drug safety, 2008, Volume: 7, Issue:6 Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline	2008
Varenicline for tobacco dependence. The New England journal of medicine, 2008, Nov-06, Volume: 359, Issue:19 Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2008
Update in new medications for primary care. Journal of general internal medicine, 2009, Volume: 24, Issue:1 Topics: Animals; Antihypertensive Agents; Benzazepines; Drugs, Investigational; Humans; Primary Health Care; Quinoxalines; Smoking Cessation; Varenicline	2009
New findings on nicotine addiction and treatment. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55 Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline	2009
Tobacco smoking cessation management: integrating varenicline in current practice. Vascular health and risk management, 2008, Volume: 4, Issue:4 Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Pharmacotherapy for smoking cessation. Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline	2008
Interventions for preventing weight gain after smoking cessation. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain	2009
Smoking in pregnancy and lactation: a review of risks and cessation strategies. European journal of clinical pharmacology, 2009, Volume: 65, Issue:4 Topics: Adult; Alkaloids; Antidepressive Agents; Azocines; Benzazepines; Breast Feeding; Bromocriptine; Cognitive Behavioral Therapy; Female; Humans; Lactation; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinolizines; Quinoxalines; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Vaccines; Varenicline; Young Adult	2009
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs]. Przeglad lekarski, 2008, Volume: 65, Issue:10 Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2008
A preliminary benefit-risk assessment of varenicline in smoking cessation. Drug safety, 2009, Volume: 32, Issue:2 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2009
Emerging drugs for the treatment of tobacco dependence. Expert opinion on emerging drugs, 2009, Volume: 14, Issue:1 Topics: Animals; Benzazepines; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2009
Varenicline: a first-line treatment option for smoking cessation. Clinical therapeutics, 2009, Volume: 31, Issue:3 Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Update on smoking cessation therapies. Advances in therapy, 2009, Volume: 26, Issue:4 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline	2009
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. International journal of environmental research and public health, 2009, Volume: 6, Issue:1 Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2009
Pharmacogenetics of smoking cessation therapy. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2010, Jan-05, Volume: 153B, Issue:1 Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline	2010
A longer course of varenicline therapy improves smoking cessation rates. Preventive cardiology, 2008,Fall, Volume: 11, Issue:4 Topics: Benzazepines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Patient Compliance; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Risk Assessment; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2008
Tobacco use among individuals with intellectual or developmental disabilities: a brief review. Intellectual and developmental disabilities, 2009, Volume: 47, Issue:3 Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline	2009
Varenicline: a novel pharmacotherapy for smoking cessation. Drugs, 2009, Jul-09, Volume: 69, Issue:10 Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Humans; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2009
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. Therapeutic advances in respiratory disease, 2009, Volume: 3, Issue:4 Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2009
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:11 Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2009
Varenicline in the management of smoking cessation: a single technology appraisal. Health technology assessment (Winchester, England), 2009, Volume: 13 Suppl 2 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Nicotinic Agonists; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Varenicline	2009
Nicotine dependence and smoking cessation. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2009, Volume: 34, Issue:11 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2009
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2 Topics: Alcohol Drinking; Animals; Behavior, Addictive; Benzazepines; Brain; Dopamine; Drug Partial Agonism; Humans; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Secondary Prevention; Smoking Cessation; Substance-Related Disorders; Varenicline	2010
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. International journal of chronic obstructive pulmonary disease, 2009, Volume: 4 Topics: Benzazepines; Cardiovascular Diseases; Drug Labeling; Humans; Mental Disorders; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Current approaches to pharmacotherapy for smoking cessation. Therapeutic advances in respiratory disease, 2010, Volume: 4, Issue:1 Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline	2010
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. PharmacoEconomics, 2010, Volume: 28, Issue:3 Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Varenicline use in patients with mental illness: an update of the evidence. Expert opinion on drug safety, 2010, Volume: 9, Issue:3 Topics: Benzazepines; Evidence-Based Medicine; Humans; Limbic System; Mental Disorders; Mood Disorders; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Suicide; Treatment Outcome; Varenicline	2010
Smoking cessation intervention: an evidence-based approach. Postgraduate medicine, 2010, Volume: 122, Issue:2 Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2010
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis. Drug safety, 2010, Apr-01, Volume: 33, Issue:4 Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Sleep Wake Disorders; Smoking Cessation; Varenicline	2010
[Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 135, Issue:5 Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Corpus Striatum; Dopamine; Humans; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Varenicline in smoking cessation. Expert review of respiratory medicine, 2010, Volume: 4, Issue:3 Topics: Animals; Benzazepines; Drug Administration Schedule; Drug Approval; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2010
Smoking cessation-recent advances. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline	2010
Comparison of available treatments for tobacco addiction. Current psychiatry reports, 2010, Volume: 12, Issue:5 Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2010
Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries. Current medical research and opinion, 2010, Volume: 26, Issue:9 Topics: Adult; Aged; Asia; Asian People; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nicotinic Agonists; Placebos; Population; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome; Varenicline	2010
[Preventive relapse treatment for tobacco cessation - is it worthwhile?]. Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8 Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline	2010
Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation. CNS drugs, 2010, Volume: 24, Issue:9 Topics: Benzazepines; Cost-Benefit Analysis; Health Care Costs; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline. Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22, Issue:10 Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline	2010
Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Health technology assessment (Winchester, England), 2010, Volume: 14, Issue:49 Topics: Benzazepines; Cost-Benefit Analysis; Evidence-Based Medicine; Health Promotion; Humans; Nicotinic Agonists; Piperidines; Public Health; Pyrazoles; Qualitative Research; Quinoxalines; Rimonabant; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Marketing; State Medicine; Treatment Failure; United Kingdom; Varenicline	2010
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clinical pharmacokinetics, 2010, Volume: 49, Issue:12 Topics: Adolescent; Adult; Age Factors; Aged; Animals; Benzazepines; Biological Availability; Drug Interactions; Half-Life; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline; Young Adult	2010
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment. Current medicinal chemistry, 2011, Volume: 18, Issue:1 Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2011
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs, 2010, Dec-24, Volume: 70, Issue:18 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12 Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2010
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2 Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2011
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. Primary care, 2011, Volume: 38, Issue:1 Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline	2011
Pharmacotherapy for smoking cessation: present and future. Current pharmaceutical design, 2011, Volume: 17, Issue:14 Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2011
Varenicline for tobacco dependence: panacea or plight? Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:11 Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline	2011
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis. BMC clinical pharmacology, 2011, Sep-28, Volume: 11 Topics: Benzazepines; Double-Blind Method; Gastrointestinal Diseases; Humans; Maintenance Chemotherapy; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2011
Clinical practice. Treating smokers in the health care setting. The New England journal of medicine, 2011, Sep-29, Volume: 365, Issue:13 Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline	2011
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Paediatric drugs, 2012, Apr-01, Volume: 14, Issue:2 Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2012
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. International journal of clinical practice, 2012, Volume: 66, Issue:2 Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Humans; Markov Chains; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline	2012
Interventions for preventing weight gain after smoking cessation. The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1 Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Weight Gain	2012
[Smoking cessation in medical practice--new possibilities?]. Revue medicale suisse, 2012, Jan-25, Volume: 8, Issue:325 Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Varenicline. Profiles of drug substances, excipients, and related methodology, 2012, Volume: 37 Topics: Animals; Benzazepines; Chromatography; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Spectrum Analysis; Varenicline; X-Ray Diffraction	2012
[Effectiveness and safety of varenicline for smoking cessation]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:18 Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2012
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4 Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2012
Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. BJOG : an international journal of obstetrics and gynaecology, 2012, Volume: 119, Issue:9 Topics: Adult; Benzazepines; Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Epidemiologic Methods; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult	2012
Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Annals of medicine, 2012, Volume: 44, Issue:6 Topics: Benzazepines; Bupropion; Databases, Bibliographic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Health impact of smoking and smoking cessation strategies: current evidence. British journal of community nursing, 2012, Volume: 17, Issue:8 Topics: Benzazepines; Bupropion; Cause of Death; Counseling; Evidence-Based Medicine; Humans; Nicotinic Agonists; Nurse's Role; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Tobacco Use Cessation Devices; United Kingdom; Varenicline	2012
Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:8 Topics: Adverse Drug Reaction Reporting Systems; Attention; Benzazepines; Cognition Disorders; Disease Progression; Dose-Response Relationship, Drug; Humans; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Risk Factors; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Treatment Outcome; Varenicline	2012
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation. Journal of pharmacy practice, 2012, Volume: 25, Issue:6 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline	2012
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12 Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Neuropsychiatric adverse events of varenicline: a systematic review of published reports. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1 Topics: Adult; Aged; Benzazepines; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Smoking Prevention; Time Factors; Varenicline; Young Adult	2013
[Smoking in COPD]. Archivos de bronconeumologia, 2011, Volume: 47 Suppl 8 Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline	2011
Pharmacologic interventions for smoking cessation. Critical care nursing clinics of North America, 2006, Volume: 18, Issue:1 Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline	2006
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. International journal of clinical practice, 2006, Volume: 60, Issue:5 Topics: Benzazepines; Brain; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2006
Varenicline: a review of its use as an aid to smoking cessation therapy. CNS drugs, 2006, Volume: 20, Issue:11 Topics: Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Humans; Quinoxalines; Smoking Cessation; Varenicline	2006
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC public health, 2006, Dec-11, Volume: 6 Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2006
[New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors]. Casopis lekaru ceskych, 2006, Volume: 145, Issue:11 Topics: Animals; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Oral varenicline for smoking cessation. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:1 Topics: Administration, Oral; Animals; Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2007
Non-nicotinic therapies for smoking cessation. Annual review of pharmacology and toxicology, 2007, Volume: 47 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1 Topics: Alkaloids; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline	2007
Varenicline for smoking cessation. Expert review of neurotherapeutics, 2007, Volume: 7, Issue:2 Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2007
Varenicline: new treatment with efficacy in smoking cessation. Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43, Issue:2 Topics: Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline	2007
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline	2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Hospitalization; Humans; Internet; Physician's Role; Practice Patterns, Physicians'; Quinoxalines; Receptors, Nicotinic; Risk Reduction Behavior; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
[Varenicline--a new drug for smoking cessation]. Medizinische Monatsschrift fur Pharmazeuten, 2007, Volume: 30, Issue:3 Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Varenicline	2007
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician. Primary care, 2007, Volume: 34, Issue:1 Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
[Varenicline (Champix)]. Journal de pharmacie de Belgique, 2007, Volume: 62, Issue:1 Topics: Adult; Benzazepines; Contraindications; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2007
Smoking cessation: lessons learned from clinical trial evidence. Current opinion in cardiology, 2007, Volume: 22, Issue:4 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2007
Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends in pharmacological sciences, 2007, Volume: 28, Issue:7 Topics: Animals; Benzazepines; Drug Design; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2007
Varenicline: the newest agent for smoking cessation. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Jul-01, Volume: 64, Issue:13 Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Drug Interactions; Humans; Nicotine; Quinoxalines; Receptors, Cholinergic; Smoking Cessation; Varenicline	2007
Varenicline: progress in smoking cessation treatment. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:11 Topics: Animals; Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline	2007
Optimizing on smoke free legislation making the most of the opportunity. British journal of community nursing, 2007, Volume: 12, Issue:8 Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline	2007
Treating tobacco dependence in women. Journal of women's health (2002), 2007, Volume: 16, Issue:8 Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health	2007
Smoking cessation: an overview of treatment options with a focus on varenicline. Pharmacotherapy, 2007, Volume: 27, Issue:11 Topics: Benzazepines; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2007
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline? Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:17 Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2007
Breaking the ties of nicotine dependence. The Nurse practitioner, 2007, Volume: 32, Issue:11 Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
An update on therapeutics for tobacco dependence. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1 Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline	2008
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology, 2008, Volume: 197, Issue:3 Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline	2008
Smoking cessation and lung cancer: oncology nurses can make a difference. Seminars in oncology nursing, 2008, Volume: 24, Issue:1 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People	2008
Efficacy and safety of varenicline for smoking cessation. The American journal of medicine, 2008, Volume: 121, Issue:4 Suppl 1 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2008
[Varenicline--a new chance for smokers?]. Przeglad lekarski, 2007, Volume: 64, Issue:10 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2007
Smoking cessation in pregnancy: why, how, and what next... Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:2 Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2008

Trials

154 trial(s) available for quinoxalines and Smoking Cessation

Article	Year
Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study). Drug and alcohol dependence, 2022, 03-01, Volume: 232 Topics: Benzazepines; Bupropion; Humans; Internet; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2022
Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2022, 10-26, Volume: 24, Issue:11 Topics: Adult; Benzazepines; Cigarette Smoking; Craving; Humans; Quinoxalines; Recurrence; Smoking Cessation; Varenicline	2022
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA network open, 2022, 06-01, Volume: 5, Issue:6 Topics: Benzazepines; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2022
Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial. JAMA network open, 2022, 11-01, Volume: 5, Issue:11 Topics: Animals; Benzazepines; Female; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2022
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial. Addiction (Abingdon, England), 2023, Volume: 118, Issue:9 Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2023
The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure. Psychopharmacology, 2021, Volume: 238, Issue:2 Topics: Adult; Benzazepines; Craving; Cues; Double-Blind Method; Female; Humans; Laboratories; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Retrospective Studies; Smokers; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2021
Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. The American journal of drug and alcohol abuse, 2013, Volume: 39, Issue:2 Topics: Adult; Arousal; Behavior, Addictive; Benzazepines; Cues; Female; Frontal Lobe; Functional Neuroimaging; Humans; Learning; Male; Memory; Neural Pathways; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2013
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biological psychiatry, 2013, Oct-01, Volume: 74, Issue:7 Topics: Adolescent; Adult; Amygdala; Benzazepines; Brain Mapping; Cerebral Cortex; Double-Blind Method; Down-Regulation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Rest; Smoking Cessation; Varenicline; Young Adult	2013
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA psychiatry, 2013, Volume: 70, Issue:5 Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult	2013
Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice. International journal of clinical practice, 2013, Volume: 67, Issue:5 Topics: Adolescent; Adult; Asia; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Medication Adherence; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2013
Adapting smoking cessation treatment according to initial response to precessation nicotine patch. The American journal of psychiatry, 2013, Volume: 170, Issue:8 Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Premedication; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:11 Topics: Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Varenicline	2013
Internet versus in-person counseling for patients taking varenicline for smoking cessation. Military medicine, 2013, Volume: 178, Issue:4 Topics: Adult; Benzazepines; Counseling; Female; Humans; Internet; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline	2013
Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial. BMC medicine, 2013, May-29, Volume: 11 Topics: Adult; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
A multicentre randomized trial of combined individual and telephone counselling for smoking cessation. Preventive medicine, 2013, Volume: 57, Issue:3 Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Smoking Cessation; Smoking Prevention; Spain; Telephone; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study. Psychopharmacology, 2014, Volume: 231, Issue:1 Topics: Adolescent; Adult; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Parasympathetic Nervous System; Pituitary-Adrenal System; Quinoxalines; Saliva; Smoking Cessation; Varenicline; Young Adult	2014
A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:1 Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; India; Male; Placebo Effect; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult	2014
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2 Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Compliance; Quinoxalines; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Varenicline	2013
A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6 Topics: Adult; Benzazepines; Bipolar Disorder; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2013
Smoking topography and abstinence in adult female smokers. Addictive behaviors, 2013, Volume: 38, Issue:12 Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Cues; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult	2013
Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study. BMC public health, 2013, Sep-10, Volume: 13 Topics: Adult; Benzazepines; Canada; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Predictive Value of Tests; Quinoxalines; Reminder Systems; Risk Assessment; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Statistics, Nonparametric; Telephone; Time Factors; Treatment Outcome; Varenicline; Young Adult	2013
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult	2013
Association of deferring a quit attempt with smoking cessation success: a secondary analysis. Journal of substance abuse treatment, 2014, Volume: 46, Issue:2 Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia. Psychopharmacology, 2014, Volume: 231, Issue:4 Topics: Adult; Antipsychotic Agents; Attention; Benzazepines; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mecamylamine; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Reaction Time; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Task Performance and Analysis; Varenicline	2014
Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand. American journal of preventive medicine, 2013, Volume: 45, Issue:5 Topics: Adult; Aged; Benzazepines; Contracts; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Quinoxalines; Rural Population; Smoking Cessation; Thailand; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA, 2014, Jan-08, Volume: 311, Issue:2 Topics: Adult; Aged; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2014
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA, 2014, Jan-08, Volume: 311, Issue:2 Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes. Psychopharmacology, 2014, Volume: 231, Issue:13 Topics: Adult; Benzazepines; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Linear Models; Male; Middle Aged; Nicotinic Agonists; Perception; Placebo Effect; Prospective Studies; Quinoxalines; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2014
Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan. Psychopharmacology, 2014, Volume: 231, Issue:14 Topics: Adult; Benzazepines; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Taiwan; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2014
Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial. European heart journal, 2014, Jun-01, Volume: 35, Issue:21 Topics: Benzazepines; Cardiovascular Diseases; Diet; Exercise Therapy; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2014
Effect of varenicline on aspects of inhibitory control in smokers. Psychopharmacology, 2014, Volume: 231, Issue:18 Topics: Adult; Benzazepines; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Male; Neuropsychological Tests; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult	2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology, 2014, Volume: 231, Issue:19 Topics: Adult; Alcohol Drinking; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult	2014
Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial. Contemporary clinical trials, 2014, Volume: 38, Issue:2 Topics: Adult; Benzazepines; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Research Design; Smoking Cessation; Socioeconomic Factors; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Varenicline	2014
Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial. Addiction (Abingdon, England), 2014, Volume: 109, Issue:9 Topics: Benzazepines; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; New York City; Nicotinic Agonists; Opiate Substitution Treatment; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2014
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION). BMC public health, 2014, May-07, Volume: 14 Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Addiction (Abingdon, England), 2014, Volume: 109, Issue:8 Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Vaccines; Varenicline; Young Adult	2014
Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Clinical pharmacology and therapeutics, 2014, Volume: 96, Issue:3 Topics: Adult; Aged; Australia; Benzazepines; Canada; Chi-Square Distribution; Counseling; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Recurrence; Retreatment; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline; Young Adult	2014
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. Addiction science & clinical practice, 2014, Jun-13, Volume: 9 Topics: Adult; Benzazepines; Cross-Sectional Studies; Directly Observed Therapy; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Opioid-Related Disorders; Pilot Projects; Quinoxalines; Research Design; Self Administration; Smoking; Smoking Cessation; Substance Abuse Treatment Centers; Varenicline	2014
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. The American journal of psychiatry, 2014, Nov-01, Volume: 171, Issue:11 Topics: Adult; Aged; Benzazepines; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline	2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1 Topics: Adult; Alcoholism; Benzazepines; Brain; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2015
The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement. Addictive behaviors, 2014, Volume: 39, Issue:10 Topics: Adult; Benzazepines; Double-Blind Method; Economics, Behavioral; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Varenicline	2014
Early quit days among methadone-maintained smokers in a smoking cessation trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:11 Topics: Adult; Benzazepines; Female; Humans; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Quinoxalines; Self Efficacy; Smoking; Smoking Cessation; Time Factors; Varenicline	2014
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA, 2014, Volume: 312, Issue:2 Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:7 Topics: Adult; Benzazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2014
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study). Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:11 Topics: Adult; Aged; Benzazepines; Counseling; Female; Headache; Hospitalization; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2014
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1 Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2015
Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addictive behaviors, 2014, Volume: 39, Issue:12 Topics: Adult; Affect; Alcohol-Related Disorders; Benzazepines; Comorbidity; Craving; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult	2014
Organic cation transporter variation and response to smoking cessation therapies. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:12 Topics: Adult; Benzazepines; Female; Genetic Variation; Humans; Male; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 2; Polymorphism, Single Nucleotide; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2014
Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015, Volume: 17, Issue:1 Topics: Adolescent; Adult; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline	2015
Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study. Trials, 2014, Oct-07, Volume: 15 Topics: Affect; Benzazepines; Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Craving; Cues; England; Humans; Magnetic Resonance Imaging; Nicotinic Agonists; Quinoxalines; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Stroop Test; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation. BMC medicine, 2014, Oct-08, Volume: 12 Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
[Smoking cessation: varenicline/nicotine patch combination more effective than varenicline alone]. Praxis, 2014, Oct-15, Volume: 103, Issue:21 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2014
Impact of cigarette smoking cessation on high-density lipoprotein functionality. Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:12 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Cutaneous; Adult; Apolipoprotein A-I; Benzazepines; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholinergic Agonists; Female; Humans; Inflammation; Lipid Peroxidation; Lipids; Lipoproteins, HDL; Macrophages; Male; Malondialdehyde; Middle Aged; Nicotine; Oxidation-Reduction; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Varenicline	2014
Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial. JAMA internal medicine, 2015, Volume: 175, Issue:2 Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Failure; Varenicline	2015
Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA, 2015, Feb-17, Volume: 313, Issue:7 Topics: Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult	2015
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015, Volume: 17, Issue:4 Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; Nicotinic Agonists; Progesterone; Quinoxalines; Smoking Cessation; Transdermal Patch; Treatment Outcome; Varenicline; Women's Health	2015
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial. Journal of acquired immune deficiency syndromes (1999), 2015, Jul-01, Volume: 69, Issue:3 Topics: Adult; Algorithms; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2015
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2008
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers. European journal of clinical pharmacology, 2008, Volume: 64, Issue:11 Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Caco-2 Cells; Digoxin; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Smoking Cessation; Varenicline	2008
Varenicline improves mood and cognition during smoking abstinence. Biological psychiatry, 2009, Jan-15, Volume: 65, Issue:2 Topics: Adult; Affect; Attention; Benzazepines; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Nicotinic Agonists; Quinoxalines; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2009
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. Journal of substance abuse treatment, 2009, Volume: 36, Issue:4 Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Internet; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Sex Factors; Smoking Cessation; Smoking Prevention; Telephone; Varenicline	2009
Varenicline for smoking cessation: a placebo-controlled, randomized study. Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:3 Topics: Adolescent; Adult; Aged; Benzazepines; China; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Singapore; Smoking Cessation; Thailand; Treatment Outcome; Varenicline; Young Adult	2009
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. Journal of general internal medicine, 2009, Volume: 24, Issue:5 Topics: Adult; Affect; Benzazepines; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2009
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clinical therapeutics, 2009, Volume: 31, Issue:1 Topics: Adolescent; Area Under Curve; Benzazepines; Body Weight; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Treatment Outcome; Varenicline	2009
Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:3 Topics: Adult; Aged; Benzazepines; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult	2009
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan. PharmacoEconomics, 2009, Volume: 27, Issue:3 Topics: Adult; Aged; Benzazepines; Combined Modality Therapy; Counseling; Female; Humans; Japan; Male; Markov Chains; Middle Aged; Models, Economic; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2009
The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers. International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:4 Topics: Adolescent; Adult; Area Under Curve; Asian People; Benzazepines; China; Drug Administration Schedule; Female; Half-Life; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Young Adult	2009
Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation. International journal of environmental research and public health, 2009, Volume: 6, Issue:4 Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2009
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Addiction (Abingdon, England), 2009, Volume: 104, Issue:9 Topics: Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Varenicline	2009
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. Psychopharmacology, 2009, Volume: 207, Issue:1 Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug and alcohol dependence, 2010, Jan-01, Volume: 106, Issue:1 Topics: Adolescent; Adult; Attention; Benzazepines; Female; Humans; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Predictive Value of Tests; Psychomotor Performance; Quinoxalines; Recurrence; Regression Analysis; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult	2010
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:12 Topics: Adult; Appetite Depressants; Benzazepines; Cyclobutanes; Drug Therapy, Combination; Female; Humans; Nicotinic Agonists; Patient Dropouts; Pilot Projects; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline; Weight Gain; Young Adult	2009
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation, 2010, Jan-19, Volume: 121, Issue:2 Topics: Aged; Benzazepines; Cardiovascular Diseases; Directive Counseling; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Survival Rate; Treatment Outcome; Varenicline	2010
Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials. Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3 Topics: Adult; Alcohol Drinking; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2010
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation. Clinical pharmacology and therapeutics, 2010, Volume: 87, Issue:3 Topics: Adolescent; Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Models, Statistical; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2010
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study). Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:4 Topics: Administration, Cutaneous; Adult; Benzazepines; Emotions; Endpoint Determination; Female; Humans; Incidence; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline	2010
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological psychiatry, 2010, Apr-15, Volume: 67, Issue:8 Topics: Adolescent; Adult; Aged; Benzazepines; Brain; Cerebral Cortex; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Oxygen; Psychomotor Performance; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline; Young Adult	2010
Smoking outcome by psychiatric history after behavioral and varenicline treatment. Journal of substance abuse treatment, 2010, Volume: 38, Issue:4 Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Directive Counseling; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2010
Behavioral counseling and varenicline treatment for smoking cessation. American journal of preventive medicine, 2010, Volume: 38, Issue:5 Topics: Adult; Benzazepines; Counseling; Female; Humans; Internet; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking Cessation; Telephone; Varenicline; Washington	2010
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:6 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Humans; Male; Medication Adherence; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2010
Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:1 Topics: Administration, Cutaneous; Adult; Benzazepines; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Drug Evaluation, Preclinical; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Reproducibility of Results; Research Design; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline	2010
Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. Journal of clinical pharmacology, 2011, Volume: 51, Issue:4 Topics: Adult; Benzazepines; Cohort Studies; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Half-Life; Humans; Japan; Male; Nicotinic Agonists; Placebos; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline; Young Adult	2011
A pilot study to assess smokeless tobacco use reduction with varenicline. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:10 Topics: Adult; Behavior; Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco, Smokeless; Varenicline	2010
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction (Abingdon, England), 2010, Volume: 105, Issue:11 Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult	2010
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest, 2011, Volume: 139, Issue:3 Topics: Aged; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; France; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Spirometry; Treatment Outcome; United States; Varenicline	2011
Changes in health-related quality of life with smoking cessation treatment. European journal of public health, 2012, Volume: 22, Issue:2 Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quality of Life; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline	2012
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study. Journal of substance abuse treatment, 2011, Volume: 40, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2011
Effects of varenicline on smoking cue–triggered neural and craving responses. Archives of general psychiatry, 2011, Volume: 68, Issue:5 Topics: Adult; Basal Ganglia; Benzazepines; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline	2011
A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology, 2011, Volume: 215, Issue:4 Topics: Adolescent; Adult; Aged; Alcohol Drinking; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2011
Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study. Current medical research and opinion, 2011, Volume: 27, Issue:4 Topics: Adult; Aged; Belgium; Benzazepines; Europe; Female; Greece; Humans; Hungary; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Observation; Quinoxalines; Slovenia; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult	2011
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo. Biological psychiatry, 2011, Jun-01, Volume: 69, Issue:11 Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2011
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:5 Topics: Benzazepines; Counseling; Electronic Mail; Female; Humans; Internet; Male; Middle Aged; Multivariate Analysis; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Telecommunications; Telephone; Treatment Outcome; Varenicline	2011
Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:5 Topics: Benzazepines; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Self Report; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2011
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. Schizophrenia research, 2011, Volume: 129, Issue:1 Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking Cessation; Treatment Outcome; Varenicline	2011
Clinical shorts. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Mar-22, Volume: 183, Issue:5 Topics: Adolescent; Age Factors; Benzazepines; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Lymph Nodes; Male; Quinoxalines; Risk Assessment; Sentinel Lymph Node Biopsy; Smoking Cessation; Survival Rate; Treatment Outcome; Varenicline	2011
A pilot clinical trial of varenicline for smoking cessation in black smokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:9 Topics: Adult; Behavior Therapy; Benzazepines; Black or African American; Combined Modality Therapy; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline	2011
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:9 Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Male; Midwestern United States; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult	2011
Brain activity and emotional processing in smokers treated with varenicline. Addiction biology, 2013, Volume: 18, Issue:4 Topics: Adolescent; Adult; Affect; Aged; Amygdala; Analysis of Variance; Benzazepines; Brain; Cross-Over Studies; Double-Blind Method; Emotions; Facial Expression; Female; Functional Neuroimaging; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Photic Stimulation; Placebos; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult	2013
A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:6 Topics: Aged; Benzazepines; Counseling; Efficiency, Organizational; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Massachusetts; Middle Aged; Nicotinic Agonists; Oncology Service, Hospital; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Thoracic Surgery; Treatment Outcome; Varenicline	2011
Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Archives of internal medicine, 2011, Apr-25, Volume: 171, Issue:8 Topics: Adult; Benzazepines; Biomarkers; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; London; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline	2011
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial. Trials, 2011, May-18, Volume: 12 Topics: Benzazepines; Bupropion; Counseling; Cultural Characteristics; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Kansas; Nicotinic Agonists; Oklahoma; Patient Education as Topic; Quinoxalines; Research Design; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2011
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. The pharmacogenomics journal, 2012, Volume: 12, Issue:4 Topics: Benzazepines; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2012
Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respiratory medicine, 2011, Volume: 105, Issue:11 Topics: Benzazepines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinoxalines; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline	2011
Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study. Clinical therapeutics, 2011, Volume: 33, Issue:4 Topics: Adolescent; Adult; Africa; Aged; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Latin America; Male; Middle Aged; Middle East; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline; Young Adult	2011
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health communication, 2011, Volume: 26, Issue:8 Topics: Adult; Benzazepines; Female; Health Behavior; Humans; Male; Middle Aged; Minority Groups; Nicotinic Agonists; Patient Selection; Quinoxalines; Racial Groups; Research Design; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Varenicline	2011
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:2 Topics: Adolescent; Benzazepines; Bupropion; Double-Blind Method; Female; Humans; Male; Nausea; Pilot Projects; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult	2012
Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline. Addictive behaviors, 2011, Volume: 36, Issue:12 Topics: Adult; Aged; Behavior Therapy; Benzazepines; Counseling; Double-Blind Method; Feasibility Studies; Female; Hospitalization; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2011
Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers. Current medical research and opinion, 2011, Volume: 27, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Philippines; Prevalence; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Varenicline	2011
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy. European journal of preventive cardiology, 2012, Volume: 19, Issue:5 Topics: Belgium; Benzazepines; Cardiovascular Diseases; Cost-Benefit Analysis; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Portugal; Prevalence; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Spain; Treatment Outcome; Varenicline	2012
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Experimental and clinical psychopharmacology, 2012, Volume: 20, Issue:1 Topics: Adult; Benzazepines; Bupropion; Cognition; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2012
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS patient care and STDs, 2012, Volume: 26, Issue:1 Topics: Adult; Affect; Benzazepines; Cotinine; Dreams; Female; Follow-Up Studies; HIV Seropositivity; Humans; Indicators and Reagents; Male; Middle Aged; Nausea; Nicotinic Agonists; Ontario; Pilot Projects; Prevalence; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2012
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:3 Topics: Adult; Antipsychotic Agents; Benzazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2012
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:3 Topics: Adult; Aged; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacogenetics; Quinoxalines; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2012
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:3 Topics: Adult; Benzazepines; Drug Administration Schedule; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 76, Issue:2 Topics: Benzazepines; Early Detection of Cancer; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tomography, X-Ray Computed; Varenicline	2012
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial. Clinical pharmacology and therapeutics, 2012, Volume: 91, Issue:2 Topics: Behavior, Addictive; Benzazepines; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Characteristics; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Varenicline	2012
Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:2 Topics: Adult; Benzazepines; Female; Follow-Up Studies; Humans; Iran; Male; Nicotinic Agonists; Prevalence; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2012
[The evaluation of strengthened psychological and behavioral intervention in smoking cessation clinics]. Zhonghua nei ke za zhi, 2011, Volume: 50, Issue:12 Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Psychotherapy; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2011
Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers. Journal of substance abuse treatment, 2012, Volume: 43, Issue:3 Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Recurrence; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2012
The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:12 Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Linear Models; Male; Middle Aged; Nicotinic Agonists; Placebo Effect; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline	2012
Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers. Psychopharmacology, 2012, Volume: 223, Issue:1 Topics: Adult; Benzazepines; Computers, Handheld; Cues; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2012
The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology, 2012, Volume: 223, Issue:2 Topics: Adolescent; Adult; Aged; Attention; Benzazepines; Cognition; Drug Administration Schedule; Humans; Inhibition, Psychological; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2012
Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology, 2012, Volume: 223, Issue:3 Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2012
Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:1 Topics: Adult; Benzazepines; Cotinine; Female; Humans; Male; Middle Aged; Patient Compliance; Prospective Studies; Quinoxalines; Reward; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2013
Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:1 Topics: Adult; Benzazepines; Female; HIV Infections; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2013
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:10 Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult	2012
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Adolescent; Adult; Aged; Benzazepines; Canada; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking Cessation; United States; Varenicline	2012
Motivational Interviewing for encouraging quit attempts among unmotivated smokers: study protocol of a randomized, controlled, efficacy trial. BMC public health, 2012, Jun-19, Volume: 12 Topics: Adult; Benzazepines; Health Education; Humans; Motivation; Motivational Interviewing; Nicotinic Antagonists; Patient Selection; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2012
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology, 2012, Volume: 117, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cotinine; Counseling; Double-Blind Method; Female; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Recurrence; Sample Size; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2012
Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study. European addiction research, 2013, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Comorbidity; Depression; Female; Germany; Humans; Hypertension; Incidence; Lung Diseases, Obstructive; Male; Middle Aged; Nicotinic Agonists; Observation; Primary Health Care; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2013
Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:5 Topics: Adult; Benzazepines; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reward; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2013
Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatients. Thorax, 2013, Volume: 68, Issue:5 Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Counseling; Female; Follow-Up Studies; Humans; Incidence; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline; Young Adult	2013
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:2 Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline	2013
Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers. NeuroImage, 2013, Feb-01, Volume: 66 Topics: Adult; Amygdala; Benzazepines; Brain Mapping; Cross-Over Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Varenicline; Young Adult	2013
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. Molecular psychiatry, 2014, Volume: 19, Issue:1 Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult	2014
Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012, Volume: 24, Issue:4 Topics: Adult; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Life Style; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Severity of Illness Index; Smoking; Smoking Cessation; Varenicline	2012
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. BMC public health, 2012, Dec-06, Volume: 12 Topics: Adolescent; Adult; Aged; Benzazepines; Combined Modality Therapy; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Research Design; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline; Young Adult	2012
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenetics and genomics, 2013, Volume: 23, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline	2013
The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and alcohol dependence, 2013, Jul-01, Volume: 131, Issue:1-2 Topics: Adolescent; Adult; Behavior, Addictive; Benzazepines; Cross-Over Studies; Cues; Double-Blind Method; Female; Follow-Up Studies; Humans; Imagination; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult	2013
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA, 2006, Jul-05, Volume: 296, Issue:1 Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA, 2006, Jul-05, Volume: 296, Issue:1 Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA, 2006, Jul-05, Volume: 296, Issue:1 Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addictive behaviors, 2007, Volume: 32, Issue:5 Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Factor Analysis, Statistical; Humans; Middle Aged; Nicotinic Agonists; Psychometrics; Quinoxalines; Reinforcement, Psychology; Reproducibility of Results; Reward; Sensation; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline	2007
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers. Journal of clinical pharmacology, 2006, Volume: 46, Issue:11 Topics: Administration, Oral; Aged; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers. Journal of clinical pharmacology, 2006, Volume: 46, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting	2006
A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Current medical research and opinion, 2007, Volume: 23, Issue:4 Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinoxalines; Smoking Cessation; Smoking Prevention; Time; Time Factors; Treatment Outcome; Varenicline	2007
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation. Journal of occupational and environmental medicine, 2007, Volume: 49, Issue:4 Topics: Absenteeism; Benzazepines; Bupropion; Cost Savings; Cost-Benefit Analysis; Decision Trees; Employer Health Costs; Health Benefit Plans, Employee; Humans; Maintenance; Nicotinic Agonists; Program Evaluation; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Time Factors; Varenicline	2007
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clinical therapeutics, 2007, Volume: 29, Issue:6 Topics: Adult; Aged; Asian People; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Taiwan; Treatment Outcome; Varenicline	2007
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clinical therapeutics, 2007, Volume: 29, Issue:6 Topics: Adult; Aged; Asian People; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline	2007
Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study. Journal of clinical pharmacology, 2007, Volume: 47, Issue:11 Topics: Adolescent; Adult; Anticoagulants; Benzazepines; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Hepatocytes; Humans; International Normalized Ratio; Male; Microsomes, Liver; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Varenicline; Warfarin	2007
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Adult; Benzazepines; Chromatography, High Pressure Liquid; Cimetidine; Embryo, Mammalian; Enzyme Inhibitors; Female; Humans; Kidney; Male; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tandem Mass Spectrometry; Varenicline	2008
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax, 2008, Volume: 63, Issue:8 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline	2008
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Adult; Amphetamine; Benzazepines; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Nicotinic Agonists; Odds Ratio; Quinoxalines; Reproducibility of Results; Smoking; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Varenicline	2008

Other Studies

339 other study(ies) available for quinoxalines and Smoking Cessation

Article	Year
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis. Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:2 Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Varenicline	2022
Bupropion for smoking cessation in adolescents. Canadian family physician Medecin de famille canadien, 2021, Volume: 67, Issue:10 Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2021
Varenicline (Chantix): The Smoking Cessation Medication Prescribers May Be Avoiding. Issues in mental health nursing, 2022, Volume: 43, Issue:5 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2022
Characterising the use of varenicline: an analysis of the Australian dispensing claims data. Addiction (Abingdon, England), 2022, Volume: 117, Issue:10 Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2022
[Tobacco cessation treatment for people with schizophrenia]. Revue medicale suisse, 2022, Jun-22, Volume: 18, Issue:787 Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline	2022
Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2022, 11-12, Volume: 24, Issue:12 Topics: Adult; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2022
Initiation of Varenicline in People Hospitalized for Acute Coronary Syndrome Who Smoke. Circulation, 2023, 06-20, Volume: 147, Issue:25 Topics: Acute Coronary Syndrome; Benzazepines; Bupropion; Cognition; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2023
Essential tobacco dependence medicines in 137 countries. Addiction (Abingdon, England), 2021, Volume: 116, Issue:6 Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2021
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting. BMJ open, 2021, 05-25, Volume: 11, Issue:5 Topics: Benzazepines; Bupropion; Cohort Studies; Humans; Netherlands; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2021
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT. Annals of internal medicine, 2017, 09-19, Volume: 167, Issue:6 Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2017
Use of varenicline versus bupropion and risk of psychiatric adverse events. Addiction (Abingdon, England), 2013, Volume: 108, Issue:7 Topics: Adult; Benzazepines; Bupropion; Denmark; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Proportional Hazards Models; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2013
Adherence to varenicline and associated smoking cessation in a community-based patient setting. Journal of managed care pharmacy : JMCP, 2013, Volume: 19, Issue:2 Topics: Adult; Benzazepines; Cohort Studies; Community Health Centers; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Pennsylvania; Primary Health Care; Provider-Sponsored Organizations; Quinoxalines; Retrospective Studies; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Refusal; Varenicline	2013
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice. Mayo Clinic proceedings, 2013, Volume: 88, Issue:3 Topics: Adult; Benzazepines; Bupropion; Comparative Effectiveness Research; Dopamine Uptake Inhibitors; Drug Therapy, Combination; England; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids. Psychopharmacology, 2013, Volume: 228, Issue:2 Topics: Alkaloids; Animals; Azocines; Benzazepines; Dihydro-beta-Erythroidine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Morphine; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA internal medicine, 2013, May-13, Volume: 173, Issue:9 Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline	2013
Systematic review wins CMAJ Bruce Squires Award. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, May-14, Volume: 185, Issue:8 Topics: Awards and Prizes; Benzazepines; Canada; Cardiovascular Diseases; Humans; Nicotinic Agonists; Publications; Quinoxalines; Smoking Cessation; Varenicline	2013
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:10 Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline	2013
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Archivos de bronconeumologia, 2013, Volume: 49, Issue:8 Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2013
Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England. Drug safety, 2013, Volume: 36, Issue:7 Topics: Adult; Adverse Drug Reaction Reporting Systems; Benzazepines; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; England; Female; General Practice; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; Varenicline	2013
Commentary on "The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey" by Enger et al. Pharmacoepidemiology and drug safety, 2013, Volume: 22, Issue:7 Topics: Benzazepines; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Risk Management; Smoking Cessation; Varenicline	2013
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction (Abingdon, England), 2013, Volume: 108, Issue:8 Topics: Benzazepines; Breath Tests; Carbon Monoxide; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
[Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline]. Medicina clinica, 2014, Feb-20, Volume: 142, Issue:4 Topics: Acute Coronary Syndrome; Arthritis, Rheumatoid; Benzazepines; Electrocardiography; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2014
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions. PharmacoEconomics, 2013, Volume: 31, Issue:9 Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews. Addiction (Abingdon, England), 2013, Volume: 108, Issue:10 Topics: Alkaloids; Azocines; Behavior Therapy; Behavior, Addictive; Benzazepines; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinolizines; Quinoxalines; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2013
Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study. Psychopharmacology, 2014, Volume: 231, Issue:1 Topics: Adult; Aged; Benzazepines; Cross-Sectional Studies; Data Collection; Data Interpretation, Statistical; England; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Population; Prescription Drugs; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2014
[Results of a multidisciplinary program to quit smoking]. Revista medica de Chile, 2013, Volume: 141, Issue:3 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Care Team; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult	2013
Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study. Pharmacoepidemiology and drug safety, 2013, Volume: 22, Issue:10 Topics: Adolescent; Adult; Benzazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Maternal Exposure; Middle Aged; New Zealand; Pregnancy; Pregnancy Complications; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Time Factors; Varenicline	2013
Varenicline may reduce negative effect while aiding smoking cessation. Evidence-based medicine, 2014, Volume: 19, Issue:1 Topics: Benzazepines; Bupropion; Counseling; Depression; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome	2014
Varenicline, smoking cessation, and neuropsychiatric adverse events. The American journal of psychiatry, 2013, Volume: 170, Issue:12 Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
Varenicline and combination nicotine replacement therapy are the most effective pharmacotherapies for treating tobacco use. Evidence-based medicine, 2013, Volume: 18, Issue:6 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices	2013
Summaries for patients. Does varenicline help people with depression quit smoking? Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult	2013
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study. BMJ (Clinical research ed.), 2013, Oct-11, Volume: 347 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Depression; England; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult	2013
Impact of access restrictions on varenicline utilization. Expert review of pharmacoeconomics & outcomes research, 2013, Volume: 13, Issue:5 Topics: Adult; Benzazepines; Cohort Studies; Databases, Factual; Female; Health Benefit Plans, Employee; Humans; Insurance Coverage; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Varenicline	2013
Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level. Journal of comparative effectiveness research, 2013, Volume: 2, Issue:3 Topics: Benzazepines; Carbon Monoxide; Carboxyhemoglobin; Carcinoembryonic Antigen; Combined Modality Therapy; Cough; Counseling; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vital Capacity	2013
Effect of allopurinol on smoking. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase	2013
The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats. Addiction biology, 2015, Volume: 20, Issue:2 Topics: Animals; Benzazepines; Motor Activity; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Smoking Cessation; Varenicline	2015
Varenicline-induced coronary thrombosis. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:12 Topics: Adult; Benzazepines; Coronary Thrombosis; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2013
Still not clear that smoking cessation drugs do not cause psychiatric symptoms. BMJ (Clinical research ed.), 2013, Nov-27, Volume: 347 Topics: Benzazepines; Bupropion; Depression; Female; Humans; Male; Quinoxalines; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices	2013
Authors' reply to Davies. BMJ (Clinical research ed.), 2013, Nov-27, Volume: 347 Topics: Benzazepines; Bupropion; Depression; Female; Humans; Male; Quinoxalines; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices	2013
Increasing the dose of varenicline in patients who do not respond to the standard dose. Mayo Clinic proceedings, 2013, Volume: 88, Issue:12 Topics: Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Vomiting	2013
Reassessing the safety of varenicline. The American journal of psychiatry, 2013, Volume: 170, Issue:12 Topics: Benzazepines; Female; Humans; Male; Quinoxalines; Smoking Cessation; Suicidal Ideation; Tobacco Use Cessation Devices; Varenicline	2013
[Smoking cessation program run by anesthesiologists in a preoperative clinic]. Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:11 Topics: Anesthesiology; Benzazepines; Female; Humans; Male; Motivation; Nicotinic Agonists; Outpatient Clinics, Hospital; Patient Education as Topic; Preoperative Care; Quinoxalines; Smoking Cessation; Varenicline	2013
Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design. International journal of environmental research and public health, 2013, Dec-24, Volume: 11, Issue:1 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bipolar Disorder; Bupropion; Clinical Trials as Topic; Follow-Up Studies; Humans; Motivational Interviewing; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction (Abingdon, England), 2014, Volume: 109, Issue:3 Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult	2014
Sentiment analysis to determine the impact of online messages on smokers' choices to use varenicline. Journal of the National Cancer Institute. Monographs, 2013, Volume: 2013, Issue:47 Topics: Adult; Behavior Therapy; Benzazepines; Decision Making; Female; Humans; Male; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Media; Tobacco Use Cessation Devices; Varenicline	2013
Pharmacological treatments for smoking cessation. JAMA, 2014, Jan-08, Volume: 311, Issue:2 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices	2014
Study suggests varenicline safe and effective among adults with stable depression. Evidence-based medicine, 2014, Volume: 19, Issue:3 Topics: Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation	2014
[Safety of nicotine addiction treatment]. Przeglad lekarski, 2013, Volume: 70, Issue:10 Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia	2013
General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study. BMC family practice, 2014, Mar-20, Volume: 15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Chronic Disease; Drug Therapy, Combination; Electronic Health Records; Female; General Practitioners; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Selection; Practice Patterns, Physicians'; Quinoxalines; Research Design; Retrospective Studies; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Young Adult	2014
Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:7 Topics: Adult; Aged; Benzazepines; Endothelium, Vascular; Humans; Male; Middle Aged; Oxidative Stress; Quinoxalines; Smoking Cessation; Varenicline; Vasodilation	2014
Twelve weeks of smoking cessation therapy with varenicline increases the serum levels of apolipoprotein A-I only in the success group. Journal of cardiology, 2014, Volume: 64, Issue:4 Topics: Apolipoprotein A-I; Benzazepines; Cholesterol, HDL; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2014
Varenicline is more effective in attenuating weight gain than nicotine patch 12 months after the end of smoking cessation therapy: an observational study in Japan. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:7 Topics: Asian People; Benzazepines; Body Mass Index; Female; Humans; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Weight Gain	2014
Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort study. Drug safety, 2014, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult	2014
Association of out-of-pocket pharmacy costs with adherence to varenicline. Journal of managed care & specialty pharmacy, 2014, Volume: 20, Issue:6 Topics: Aged; Benzazepines; Community Pharmacy Services; Drug Costs; Female; Health Expenditures; Humans; Linear Models; Logistic Models; Male; Medicare; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline	2014
Understanding statistical hypothesis testing. BMJ (Clinical research ed.), 2014, May-30, Volume: 348 Topics: Adolescent; Adult; Benzazepines; Data Interpretation, Statistical; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Statistics as Topic; Tobacco Use Cessation Devices; Varenicline; Young Adult	2014
Nicotine vaccination--does it have a future? Addiction (Abingdon, England), 2014, Volume: 109, Issue:8 Topics: Benzazepines; Brain; Counseling; Cues; Female; Humans; Male; Memory, Short-Term; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Vaccines	2014
Tobacco smoking: options for helping smokers to quit. Australian family physician, 2014, Volume: 43, Issue:6 Topics: Australia; Benzazepines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; General Practice; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2014
[Abstinence rates among varenicline are highest]. Medizinische Monatsschrift fur Pharmazeuten, 2014, Volume: 37, Issue:5 Topics: Benzazepines; Bupropion; Humans; Mental Disorders; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2014
Acute generalized exanthematous pustulosis caused by varenicline. International journal of dermatology, 2014, Volume: 53, Issue:9 Topics: Acute Generalized Exanthematous Pustulosis; Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2014
[Vareniklin: a safe treatment of tobacco dependency for cardiovascular patients]. Casopis lekaru ceskych, 2014, Volume: 153, Issue:3 Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2014
Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:11 Topics: Aged; Aged, 80 and over; Benzazepines; Bupropion; Cardiovascular Diseases; Cohort Studies; Comorbidity; Female; Humans; Incidence; Male; Medicare; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; Varenicline	2014
Efficacy of varenicline for smoking cessation in bipolar disorder. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:7 Topics: Benzazepines; Bipolar Disorder; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2014
Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database. BMJ open, 2014, Aug-28, Volume: 4, Issue:8 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; General Practice; Humans; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline	2014
Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline. Psychopharmacology, 2015, Volume: 232, Issue:5 Topics: Animals; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Smoking Cessation; Varenicline	2015
Searching for phenotypes in smoking cessation treatment. International journal of clinical practice, 2014, Volume: 68, Issue:12 Topics: Adult; Aged; Behavior Therapy; Benzazepines; Bupropion; Effect Modifier, Epidemiologic; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Phenotype; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome	2014
Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers. Addictive behaviors, 2015, Volume: 40 Topics: Adult; Anxiety Disorders; Benzazepines; Bupropion; Cross-Sectional Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult	2015
Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis. BMC public health, 2014, Oct-02, Volume: 14 Topics: Adolescent; Adult; Age Distribution; Benzazepines; Databases, Factual; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Primary Health Care; Quinoxalines; Sexism; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; United Kingdom; Varenicline; Young Adult	2014
Repeating the same mistake. Prescrire international, 2014, Volume: 23, Issue:152 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2014
Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects! Prescrire international, 2014, Volume: 23, Issue:152 Topics: Benzazepines; Drug Administration Schedule; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Retreatment; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2014
Funding a smoking cessation program for Crohn's disease: an economic evaluation. The American journal of gastroenterology, 2015, Volume: 110, Issue:3 Topics: Adult; Azathioprine; Benzazepines; Canada; Cost-Benefit Analysis; Crohn Disease; Directive Counseling; Female; Humans; Immunosuppressive Agents; Male; Models, Statistical; Nicotinic Agonists; Program Evaluation; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tumor Necrosis Factor-alpha; Varenicline	2015
Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC public health, 2014, Nov-12, Volume: 14 Topics: Adolescent; Adult; Benzazepines; Cohort Studies; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Patient Compliance; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Varenicline	2014
Varenicline and abnormal sleep related events. Sleep, 2015, May-01, Volume: 38, Issue:5 Topics: Adult; Aggression; Benzazepines; Dreams; Drug Labeling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Parasomnias; Pharmacovigilance; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Somnambulism; Varenicline; World Health Organization	2015
Maintenance of tobacco cessation programmes in public hospitals in Catalonia, Spain. Addictive behaviors, 2015, Volume: 42 Topics: Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Hospitalization; Hospitals, Public; Humans; Inpatients; Nicotinic Agonists; Personnel, Hospital; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2015
Improving the success of treating tobacco smokers. JAMA internal medicine, 2015, Volume: 175, Issue:2 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2015
Treatment effects and placebo effects. BMJ (Clinical research ed.), 2015, Jan-16, Volume: 350 Topics: Benzazepines; Endpoint Determination; Humans; Nicotinic Agonists; Placebo Effect; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco, Smokeless; Treatment Outcome; Varenicline	2015
Quantifying treatment effects in randomised controlled trials. BMJ (Clinical research ed.), 2015, Jan-23, Volume: 350 Topics: Benzazepines; Humans; Outcome Assessment, Health Care; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline	2015
[Effectiveness of Varenicline with counseling programs on smoking cessation in a targeted clinical setting in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2014, Volume: 35, Issue:12 Topics: Benzazepines; China; Counseling; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2014
Smoking cessation in men and women. The American journal of psychiatry, 2014, Nov-01, Volume: 171, Issue:11 Topics: Benzazepines; Bupropion; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2014
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015, Volume: 17, Issue:4 Topics: Adolescent; Adult; Australia; Benzazepines; Canada; Female; Gender Identity; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; United Kingdom; United States; Varenicline	2015
Sex difference in response to varenicline for smoking cessation. The American journal of psychiatry, 2015, Volume: 172, Issue:4 Topics: Benzazepines; Bupropion; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
Response to Gorelick. The American journal of psychiatry, 2015, Volume: 172, Issue:4 Topics: Benzazepines; Bupropion; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
[The latest information on the forefront of the campaign against tobacco]. Revue medicale suisse, 2015, Jan-21, Volume: 11, Issue:458 Topics: Benzazepines; France; Health Promotion; Humans; Lung Neoplasms; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline	2015
[Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes]. Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 2014, Volume: 49, Issue:6 Topics: Adult; Aged; Alcohol Abstinence; Alcoholism; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline; Young Adult	2014
[Penis transplantation in South Africa. Risk of suicide using varenicline?]. Revue medicale suisse, 2015, Mar-25, Volume: 11, Issue:467 Topics: Adult; Benzazepines; China; Communications Media; Graft Survival; Humans; Male; Penile Transplantation; Quinoxalines; Sexual Dysfunction, Physiological; Smoking Cessation; South Africa; Suicide; Transplant Recipients; Varenicline; Young Adult	2015
Varenicline for smoking cessation in the bipolar patient. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Benzazepines; Bipolar Disorder; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation	2015
Dr Chengappa and colleagues reply. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Benzazepines; Bipolar Disorder; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation	2015
Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study. BMJ (Clinical research ed.), 2015, Jun-02, Volume: 350 Topics: Accidents, Traffic; Adolescent; Adult; Aged; Benzazepines; Cohort Studies; Crime; Epidemiologic Methods; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult	2015
Varenicline for smoking reduction prior to cessation. JAMA, 2015, Jun-09, Volume: 313, Issue:22 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
Varenicline for smoking reduction prior to cessation. JAMA, 2015, Jun-09, Volume: 313, Issue:22 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
Varenicline for smoking reduction prior to cessation--reply. JAMA, 2015, Jun-09, Volume: 313, Issue:22 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
Varenicline can help smokers to stop smoking by gradual reduction. Evidence-based medicine, 2015, Volume: 20, Issue:4 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder	2015
Formative Evaluation of a Text Messaging Intervention to Promote Varenicline Adherence Among Tobacco-Dependent Persons with HIV. Journal of health communication, 2015, Volume: 20, Issue:9 Topics: Adult; Benzazepines; Feasibility Studies; Female; Focus Groups; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Program Evaluation; Quinoxalines; Smoking Cessation; Text Messaging; Tobacco Use Disorder; Varenicline	2015
[Varenicline to stop smoking progressively]. Revue medicale suisse, 2015, May-20, Volume: 11, Issue:475 Topics: Benzazepines; Humans; Multicenter Studies as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Varenicline	2015
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey. Turkish journal of medical sciences, 2015, Volume: 45, Issue:4 Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline	2015
Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy. Osaka city medical journal, 2015, Volume: 61, Issue:1 Topics: Adult; Aged; Benzazepines; Brachial Artery; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Nitroglycerin; Quinoxalines; Recovery of Function; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Ultrasonography; Varenicline; Vasodilation; Vasodilator Agents; Young Adult	2015
Varenicline, combination NRT, and nicotine patch did not differ for smoking cessation at 6 mo. Annals of internal medicine, 2016, 05-17, Volume: 164, Issue:10 Topics: Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline	2016
Gender difference and effect of pharmacotherapy: findings from a smoking cessation service. BMC public health, 2016, 10-03, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult	2016
Exacerbation of recurrent depression as a result of treatment with varenicline. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline	2008
Updated US smoking cessation guideline advises counseling, combining therapies. JAMA, 2008, Jun-18, Volume: 299, Issue:23 Topics: Behavior Therapy; Benzazepines; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; United States; Varenicline	2008
New kid on the block: Chantix for smoking cessation. Texas dental journal, 2008, Volume: 125, Issue:5 Topics: Administration, Oral; Benzazepines; Drug Administration Schedule; Drug Approval; Humans; Nausea; Quinoxalines; Receptors, Cholinergic; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Varenicline	2008
Varenicline reduced smoking behaviour in a mentally ill person. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:3 Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2009
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS spectrums, 2008, Volume: 13, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline	2008
Varenicline efficacy and tolerability in a subject with schizophrenia. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; Benzazepines; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline	2008
Diffuse exanthema in a patient receiving varenicline. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Jul-01, Volume: 65, Issue:13 Topics: Aged; Benzazepines; Exanthema; Female; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2008
Varenicline (Chantix) warnings: risk versus benefit. The Medical letter on drugs and therapeutics, 2008, Jul-14, Volume: 50, Issue:1290 Topics: Benzazepines; Drug Partial Agonism; Humans; Mental Disorders; Nicotinic Agonists; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Varenicline: depression and suicide. Nicotine is a safer option. Prescrire international, 2008, Volume: 17, Issue:95 Topics: Benzazepines; Depression; Humans; Nicotine; Quinoxalines; Smoking Cessation; Suicide	2008
The place of varenicline in smoking cessation treatment. Thorax, 2008, Volume: 63, Issue:8 Topics: Benzazepines; Bupropion; Cholinergic Agents; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Drug Costs; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2008
Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field. Thorax, 2008, Volume: 63, Issue:8 Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline	2008
Clinically significant outcomes in smoking cessation. Thorax, 2008, Volume: 63, Issue:8 Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2008
Varenicline treatment for smokers with schizophrenia: a case series. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:6 Topics: Benzazepines; Cholinergic Agonists; Drug Administration Schedule; Humans; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2008
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-01, Volume: 65, Issue:17 Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2008
The risk-benefit balance of varenicline for smoking cessation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:9 Topics: Benzazepines; Humans; Quinoxalines; Risk Assessment; Smoking Cessation; Varenicline	2008
Varenicline and suicidality: a new era in medication safety surveillance. Expert opinion on drug safety, 2008, Volume: 7, Issue:5 Topics: Adverse Drug Reaction Reporting Systems; Benzazepines; Depression; Drug Labeling; Humans; Psychomotor Agitation; Quinoxalines; Smoking Cessation; Suicide; Suicide Prevention; Varenicline	2008
Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome. Acta neurologica Scandinavica, 2009, Volume: 119, Issue:2 Topics: Ataxia; Benzazepines; Brain; Dreams; Fragile X Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Postural Balance; Quinoxalines; Smoking; Smoking Cessation; Tremor; Varenicline	2009
First in class. Scientific American, 2008, Volume: 299, Issue:3 Topics: Benzazepines; Humans; Psychoses, Substance-Induced; Quinoxalines; Receptors, Nicotinic; Seizures; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2008
[Varenicline for smoking cessation]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Sep-11, Volume: 128, Issue:17 Topics: Benzazepines; Humans; Quinoxalines; Smoking Cessation; Varenicline	2008
Smoking cessation: the psychiatrist's role. Journal of psychiatry & neuroscience : JPN, 2008, Volume: 33, Issue:5 Topics: Antimanic Agents; Benzazepines; Bipolar Disorder; Bupropion; Humans; Lithium Carbonate; Psychiatry; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline	2008
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tobacco control, 2009, Volume: 18, Issue:1 Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline	2009
Varenicline-associated acute renal failure. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:12 Topics: Acute Kidney Injury; Benzazepines; Creatinine; Drug Monitoring; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Varenicline	2008
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2008
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area	2009
Smoking cessation: new ways to quit. Harvard men's health watch, 2008, Volume: 13, Issue:4 Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Behavior, Addictive; Benzazepines; Bupropion; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2008
Varenicline and smokers with mental illnesses. Lancet (London, England), 2008, Oct-04, Volume: 372, Issue:9645 Topics: Benzazepines; Humans; Mental Disorders; Patient Selection; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Varenicline	2008
[Drug treatment for smoking and marijuana abuse]. Revue des maladies respiratoires, 2008, Volume: 25, Issue:10 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Humans; Marijuana Abuse; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2008
The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:1 Topics: Animals; Benzazepines; Central Nervous System Depressants; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Limbic System; Male; Microdialysis; Nicotine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Smoking Cessation; Varenicline	2009
A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA, 2009, Feb-04, Volume: 301, Issue:5 Topics: Benzazepines; Bipolar Disorder; Bupropion; Counseling; Female; Humans; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2009
[Specific program for smoking cessation: thus your patients become nonsmokers]. MMW Fortschritte der Medizin, 2008, Nov-13, Volume: 150, Issue:46 Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. BMC public health, 2009, Jan-21, Volume: 9 Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult	2009
Acute generalized exanthematous pustulosis caused by varenicline. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:9 Topics: Adult; Benzazepines; Biopsy; Drug Eruptions; Female; Humans; Nicotinic Agonists; Psoriasis; Quinoxalines; Skin; Smoking Cessation; Varenicline	2009
Varenicline, appetite, and weight reduction. The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4 Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss	2008
Suicidal ideation and varenicline: a possible case of mistaken adverse drug reaction? The Journal of clinical psychiatry, 2008, Volume: 69, Issue:11 Topics: Adult; Benzazepines; Humans; Male; Quinoxalines; Self-Injurious Behavior; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Suicide; Suicide Prevention; Varenicline	2008
Varenicline for tobacco dependence. The New England journal of medicine, 2009, Feb-12, Volume: 360, Issue:7 Topics: Affect; Behavior; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Suicide; Tobacco Use Disorder; Varenicline	2009
Antismoking drug still recommended to Canadians despite side effects and US advisory. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2009, Feb-17, Volume: 180, Issue:4 Topics: Benzazepines; Canada; Humans; Quinoxalines; Smoking Cessation; United States; Varenicline	2009
[Varenicline - pharmacological therapy of tobacco dependence]. Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:1-2 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Clinical Trials as Topic; Contraindications; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Pregnancy; Prospective Studies; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline	2009
Persistent genital arousal disorder: a case report in a woman with lifelong PGAD where serendipitous administration of varenicline tartrate resulted in symptomatic improvement. The journal of sexual medicine, 2009, Volume: 6, Issue:5 Topics: Benzazepines; Central Nervous System Agents; Female; Humans; Middle Aged; Quinoxalines; Receptors, Dopamine; Receptors, Nicotinic; Sexual Dysfunctions, Psychological; Smoking Cessation; Varenicline	2009
Smoking cessation with varenicline: a suicidal fatality. Journal of analytical toxicology, 2009, Volume: 33, Issue:2 Topics: Adult; Benzazepines; Fatal Outcome; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Suicide; Tandem Mass Spectrometry; Varenicline	2009
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months". Medscape journal of medicine, 2008, Volume: 10, Issue:12 Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
Studies linking smoking-cessation drug with suicide risk spark concerns. JAMA, 2009, Mar-11, Volume: 301, Issue:10 Topics: Adverse Drug Reaction Reporting Systems; Affect; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Risk; Smoking Cessation; Suicide; United States; Varenicline; Wounds and Injuries	2009
[Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain]. Anales de medicina interna (Madrid, Spain : 1984), 2008, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Spain; Varenicline; Young Adult	2008
Varenicline augmentation in depressed smokers: an 8-week, open-label study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:7 Topics: Adolescent; Adult; Aged; Benzazepines; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychotropic Drugs; Quinoxalines; Receptors, Nicotinic; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Combination treatment with varenicline and nicotine replacement therapy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:5 Topics: Adult; Aged; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking Cessation; Varenicline	2009
Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient. The Journal of neuropsychiatry and clinical neurosciences, 2009,Winter, Volume: 21, Issue:1 Topics: Adult; Antipsychotic Agents; Benzazepines; Humans; Male; Psychiatric Status Rating Scales; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Varenicline	2009
Two recent updates for psychiatric conditions. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline	2009
Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzazepines; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline; Veterans	2009
Varenicline: the French experience after 6 months. Prescrire international, 2009, Volume: 18, Issue:99 Topics: Benzazepines; France; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation	2009
Hallucinations in the context of varenicline withdrawal. The American journal of psychiatry, 2009, Volume: 166, Issue:5 Topics: Adult; Benzazepines; Cholinergic Agonists; Hallucinations; Humans; Male; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline	2009
Reduced affective symptoms during tobacco dependence treatment with varenicline. Addiction (Abingdon, England), 2009, Volume: 104, Issue:5 Topics: Affective Symptoms; Benzazepines; Depressive Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link? Addiction (Abingdon, England), 2009, Volume: 104, Issue:5 Topics: Benzazepines; Humans; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Suicide; United Kingdom; Varenicline	2009
Treatment of comorbid tobacco use in people with serious mental illness. Journal of psychiatry & neuroscience : JPN, 2009, Volume: 34, Issue:3 Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline	2009
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. Drug safety, 2009, Volume: 32, Issue:6 Topics: Adult; Benzazepines; Drug Prescriptions; Drug Utilization; England; Family Practice; Female; Humans; Male; Middle Aged; Quinoxalines; Safety; Smoking Cessation; Varenicline	2009
Varenicline and proximal myopathy. The Medical journal of Australia, 2009, Jun-01, Volume: 190, Issue:11 Topics: Adult; Benzazepines; Follow-Up Studies; Humans; Male; Myotonic Disorders; Quinoxalines; Smoking Cessation; Varenicline	2009
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries. European journal of public health, 2009, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult	2009
[Current and future medical drugs for smoking cessation]. Laryngo- rhino- otologie, 2009, Volume: 88, Issue:6 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline	2009
Cost-effectiveness of varenicline for smoking cessation. Expert review of pharmacoeconomics & outcomes research, 2009, Volume: 9, Issue:3 Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2009
Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence. Journal of evaluation in clinical practice, 2009, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Benzazepines; Costs and Cost Analysis; Female; Humans; Male; Middle Aged; Models, Theoretical; Quinoxalines; Smoking; Smoking Cessation; Sweden; Treatment Outcome; Varenicline; Young Adult	2009
Varenicline: a British review. Unfavorable risk-benefit balance. Prescrire international, 2008, Volume: 17, Issue:97 Topics: Benzazepines; France; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; United Kingdom	2008
Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. Pharmacotherapy, 2009, Volume: 29, Issue:7 Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Smoking Cessation; Varenicline	2009
Acute hepatic injury associated with varenicline in a patient with underlying liver disease. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:9 Topics: Acute Disease; Benzazepines; Hepatitis C; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2009
Safety of smoking cessation drugs. The Medical letter on drugs and therapeutics, 2009, Aug-24, Volume: 51, Issue:1319 Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2009
Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use. Muscle & nerve, 2009, Volume: 40, Issue:3 Topics: Benzazepines; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Middle Aged; Quinoxalines; Smoking Cessation; Varenicline	2009
Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy. Acta bio-medica : Atenei Parmensis, 2009, Volume: 80, Issue:1 Topics: Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; Directive Counseling; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline	2009
Varenicline gets stronger warnings about psychiatric problems, vehicle crashes. JAMA, 2009, Aug-26, Volume: 302, Issue:8 Topics: Accidents, Traffic; Benzazepines; Bupropion; Drug Labeling; Humans; Neurotransmitter Agents; Quinoxalines; Receptors, Nicotinic; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline	2009
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis. Clinical drug investigation, 2009, Volume: 29, Issue:10 Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2009
Smoking cessation: how to advise the patient. Heart (British Cardiac Society), 2009, Volume: 95, Issue:19 Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline	2009
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ (Clinical research ed.), 2009, Oct-01, Volume: 339 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult	2009
Smoking cessation agents and suicide. BMJ (Clinical research ed.), 2009, Nov-05, Volume: 339 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Quinoxalines; Self-Injurious Behavior; Smoking Cessation; Suicide; Varenicline; Young Adult	2009
[Drug treatment of tobacco dependence]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:47 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2009
Population pharmacokinetic analysis of varenicline in adult smokers. British journal of clinical pharmacology, 2009, Volume: 68, Issue:5 Topics: Adult; Benzazepines; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Models, Biological; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Renal Insufficiency; Smoking; Smoking Cessation; Varenicline; Young Adult	2009
A retrospective poison center review of varenicline-exposed patients. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:12 Topics: Adolescent; Adult; Benzazepines; Child, Preschool; Databases, Factual; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infant; Male; Medication Errors; Mental Disorders; Nicotinic Agonists; Poison Control Centers; Quinoxalines; Retrospective Studies; Smoking Cessation; Varenicline	2009
Varenicline and antiretroviral therapy in patients with HIV. Journal of acquired immune deficiency syndromes (1999), 2009, Volume: 52, Issue:5 Topics: Anti-Retroviral Agents; Benzazepines; Cardiovascular Diseases; Female; HIV Infections; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2009
Regulation of smoking cessation drugs by the Food and Drug Administration. Food and drug law journal, 2009, Volume: 64, Issue:2 Topics: Benzazepines; Clinical Trials as Topic; Drug Approval; Drug Interactions; Government Regulation; Humans; Mental Disorders; Nicotinic Agonists; Product Surveillance, Postmarketing; Psychotropic Drugs; Quinoxalines; Smoking; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2009
Varenicline for smoking cessation in patients with coronary heart disease. Circulation, 2010, Jan-19, Volume: 121, Issue:2 Topics: Benzazepines; Cardiovascular Diseases; Coronary Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2010
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers. Current medical research and opinion, 2010, Volume: 26, Issue:3 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Costs and Cost Analysis; Databases, Factual; Dopamine Uptake Inhibitors; Female; Finland; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study. Current medical research and opinion, 2010, Volume: 26, Issue:4 Topics: Benzazepines; Family Practice; Female; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Motivation; Nicotinic Agonists; Prevalence; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; United Kingdom; Varenicline	2010
Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia. Schizophrenia research, 2010, Volume: 119, Issue:1-3 Topics: Antipsychotic Agents; Benzazepines; Drinking; Drug Therapy, Combination; Humans; Hyponatremia; Male; Middle Aged; Nicotinic Agonists; Psychoses, Substance-Induced; Quinoxalines; Schizophrenia; Smoking Cessation; Varenicline; Water Intoxication	2010
Thiopurine S-methyltransferase deficiency associated with a novel mutation. Inflammatory bowel diseases, 2010, Volume: 16, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Male; Mesalamine; Methyltransferases; Mutation; Neutrophils; Nicotinic Agonists; Prednisolone; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2010
Varenicline and pheochromocytoma. Annals of internal medicine, 2010, Mar-02, Volume: 152, Issue:5 Topics: Adrenal Gland Neoplasms; Benzazepines; Female; Humans; Middle Aged; Nicotinic Agonists; Pheochromocytoma; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2010
Integrating smoking cessation into HIV care. AIDS patient care and STDs, 2010, Volume: 24, Issue:3 Topics: Anti-HIV Agents; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Government Programs; HIV Infections; Humans; Nicotinic Agonists; Oregon; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2010
Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence. Psychopharmacology, 2010, Volume: 210, Issue:1 Topics: Adult; Benzazepines; Female; Humans; Male; Prospective Studies; Quinoxalines; Retrospective Studies; Reward; Single-Blind Method; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2010
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. British journal of pharmacology, 2010, Volume: 160, Issue:2 Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azepines; Azocines; Benzazepines; Brain; Dopamine; Heterocyclic Compounds, 4 or More Rings; Humans; Limbic System; Male; Mice; Mice, Knockout; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder; Varenicline; Xenopus laevis	2010
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers. Schizophrenia research, 2010, Volume: 119, Issue:1-3 Topics: Benzazepines; Cotinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Gene Expression; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; RNA, Messenger; Schizophrenia; Smoking Cessation; Varenicline	2010
Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Human psychopharmacology, 2010, Volume: 25, Issue:3 Topics: Adult; Aged; Benzazepines; Brain-Derived Neurotrophic Factor; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:6 Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Humans; Male; Montana; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2010
Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation. CNS spectrums, 2010, Volume: 15, Issue:3 Topics: Adult; Antidepressive Agents; Benzazepines; Depressive Disorder; Humans; Male; Quinoxalines; Sertraline; Smoking Cessation; Varenicline	2010
Current treatment options in smoking cessation. Hospital practice (1995), 2010, Volume: 38, Issue:1 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline	2010
Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Drug Costs; Drug Labeling; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; Time Factors; Varenicline; Young Adult	2010
The use of snus for quitting smoking compared with medicinal products. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:8 Topics: Adult; Benzazepines; Chewing Gum; Data Collection; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Regression Analysis; Smoking Cessation; Tobacco, Smokeless; Varenicline	2010
Thoughts and acts of aggression/violence toward others reported in association with varenicline. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:9 Topics: Adult; Aggression; Benzazepines; Female; Humans; Male; Mental Disorders; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Thinking; Varenicline; Violence	2010
[The management of patients with nicotine dependence - the role of the general practitioners]. Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8 Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline	2010
[Medical therapy for smoking cessation]. Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8 Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2010
Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial". Circulation, 2010, Aug-31, Volume: 122, Issue:9 Topics: Benzazepines; Cardiovascular Diseases; Depression; Humans; Nicotinic Agonists; Patient Selection; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Varenicline	2010
Nicotine gum dependence treated with varenicline--a case report. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:10 Topics: Adult; Benzazepines; Female; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2010
Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis. The American journal of managed care, 2010, Volume: 16, Issue:9 Topics: Adult; Benzazepines; Cohort Studies; Drug Therapy; Female; Humans; Insurance Claim Review; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; United States; Varenicline	2010
Clinical experience of varenicline for smoking cessation. The clinical respiratory journal, 2010, Volume: 4, Issue:4 Topics: Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outpatient Clinics, Hospital; Patient Compliance; Quinoxalines; Republic of Korea; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult	2010
Electroconvulsive therapy (ECT) effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2010, Volume: 32, Issue:3 Topics: Benzazepines; Electroconvulsive Therapy; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking Cessation; Suicidal Ideation; Varenicline	2010
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug and alcohol dependence, 2011, Mar-01, Volume: 114, Issue:1 Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult	2011
Mental health stability in veterans with posttraumatic stress disorder receiving varenicline. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Nov-01, Volume: 67, Issue:21 Topics: Benzazepines; Female; Hospitals, Veterans; Humans; Male; Mental Health Services; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Varenicline; Veterans	2010
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:1 Topics: Animals; Benzazepines; Cerebral Cortex; Hippocampus; Male; Mice; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Thalamus; Up-Regulation; Varenicline	2011
[Sustainable efficacy of oral varenicline for smoking cessation]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:11 Topics: Administration, Oral; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2010
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:2 Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult	2011
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation. European journal of pharmacology, 2011, Mar-01, Volume: 654, Issue:1 Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Reinforcement Schedule; Smoking Cessation; Time Factors; Varenicline	2011
Varenicline (champix)-associated manic relapse in bipolar affective disorder. Irish medical journal, 2010, Volume: 103, Issue:9 Topics: Benzazepines; Bipolar Disorder; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2010
Australia's experience with varenicline: usage, costs and adverse reactions. Addiction (Abingdon, England), 2011, Volume: 106, Issue:2 Topics: Australia; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2011
Adynamic ileus induced by varenicline. Current drug safety, 2011, Feb-01, Volume: 6, Issue:1 Topics: Aged; Benzazepines; Humans; Ileus; Male; Quinoxalines; Smoking Cessation; Varenicline	2011
Pharmacotherapy for smoking. Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:1 Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2011
Integrating results from smoking cessation drug research and development into clinical occupational health practice. AAOHN journal : official journal of the American Association of Occupational Health Nurses, 2011, Volume: 59, Issue:2 Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2011
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2 Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus	2011
Varenicline-induced grand mal seizure. Epileptic disorders : international epilepsy journal with videotape, 2010, Volume: 12, Issue:4 Topics: Benzazepines; Diagnosis, Differential; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Tonic-Clonic; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2010
Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. International journal of environmental research and public health, 2011, Volume: 8, Issue:1 Topics: Adult; Age Factors; Australia; Benzazepines; Canada; Cohort Studies; Cross-Cultural Comparison; Cross-Sectional Studies; Drug Utilization; Female; Health Surveys; Humans; International Cooperation; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Self Report; Sex Factors; Smoking Cessation; Socioeconomic Factors; United Kingdom; United States; Varenicline	2011
Effectiveness of varenicline for smoking cessation: a 1-year follow-up study. Journal of substance abuse treatment, 2011, Volume: 41, Issue:1 Topics: Adult; Benzazepines; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Varenicline	2011
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care]. Atencion primaria, 2011, Volume: 43, Issue:9 Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult	2011
Prescribing of smoking cessation medication in England since the introduction of varenicline. Addiction (Abingdon, England), 2011, Volume: 106, Issue:7 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline	2011
Varenicline induced mania in a 51 year old patient without history of bipolar illness. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4 Topics: Benzazepines; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Nicotinic Agonists; Paranoid Disorders; Patient Admission; Quinoxalines; Smoking Cessation; Varenicline	2011
Correlation between willing to smoking cessation and treatment outcome of health care workers in Thailandt. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011, Volume: 94, Issue:1 Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Follow-Up Studies; Health Personnel; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Patient Acceptance of Health Care; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Surveys and Questionnaires; Thailand; Treatment Outcome; Varenicline; Young Adult	2011
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data. PharmacoEconomics, 2011, Volume: 29, Issue:6 Topics: Adult; Benzazepines; Clinical Trials as Topic; Female; Health Care Costs; Humans; Male; Models, Statistical; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2011
What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD? Chest, 2011, Volume: 139, Issue:4 Topics: Benzazepines; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline	2011
A case of late-life onset mania during Varenicline assisted smoking cessation. International journal of geriatric psychiatry, 2011, Volume: 26, Issue:6 Topics: Age of Onset; Aged; Antimanic Agents; Antipsychotic Agents; Benzazepines; Bipolar Disorder; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2011
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims. Clinical therapeutics, 2011, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aged; Benzazepines; Cohort Studies; Cost Sharing; Female; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; United States; Varenicline; Young Adult	2011
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking". Archives of internal medicine, 2011, Apr-25, Volume: 171, Issue:8 Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline	2011
Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications? Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:9 Topics: Adult; Benzazepines; Bupropion; Drug Utilization; England; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline	2011
Varenicline and the evaluation of neuropsychiatric adverse events in smokers. Biological psychiatry, 2011, Jun-01, Volume: 69, Issue:11 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2011
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation. Addiction (Abingdon, England), 2011, Volume: 106, Issue:10 Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales	2011
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England. Addiction (Abingdon, England), 2011, Volume: 106, Issue:10 Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult	2011
Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia. Psychiatry research, 2011, Nov-30, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Benzazepines; Cognition; Humans; Male; Middle Aged; Mood Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2011
Smoking cessation pharmacotherapy: a concise overview. Advance for NPs & PAs, 2011, Volume: 2, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2011
Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity. Psychopharmacology, 2012, Volume: 219, Issue:1 Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Psychomotor Performance; Quinoxalines; Reward; Schizophrenia; Smoking; Smoking Cessation; Varenicline	2012
Assessing preferences for improved smoking cessation medications: a discrete choice experiment. The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:5 Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult	2012
The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice. Pharmacology, biochemistry, and behavior, 2011, Volume: 100, Issue:1 Topics: Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Evoked Potentials, Auditory; Male; Mice; Mice, Inbred DBA; Neural Inhibition; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2011
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success. The Harvard mental health letter, 2011, Volume: 27, Issue:10 Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline	2011
Estimating the rate of usage of varenicline and other medication for smoking cessation. Addiction (Abingdon, England), 2011, Volume: 106, Issue:10 Topics: Benzazepines; Humans; Models, Statistical; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation	2011
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. Drug safety, 2011, Sep-01, Volume: 34, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Prospective Studies; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult	2011
Treatment of nicotine dependence with Chantix (varenicline). Texas dental journal, 2011, Volume: 128, Issue:5 Topics: Adult; Benzazepines; Disclosure; Drug Interactions; Humans; Mental Disorders; Nausea; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2011
In brief: Cardiovascular safety of varenicline (Chantix). The Medical letter on drugs and therapeutics, 2011, Aug-22, Volume: 53, Issue:1371 Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2011
Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis. Addictive behaviors, 2011, Volume: 36, Issue:12 Topics: Benzazepines; Double-Blind Method; Humans; Motivation; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Varenicline	2011
Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. Addiction (Abingdon, England), 2012, Volume: 107, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Policy; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Varenicline; Vietnam; Young Adult	2012
[Clinical study of smoking cessation clinic subjects]. Nihon Jibiinkoka Gakkai kaiho, 2011, Volume: 114, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outpatient Clinics, Hospital; Outpatients; Quinoxalines; Smoking Cessation; Varenicline	2011
[Smoking cessation--assistance for the general practitioner]. MMW Fortschritte der Medizin, 2011, Apr-07, Volume: 153, Issue:14 Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2011
Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:3 Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder; Varenicline	2012
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:4 Topics: Adult; Benzazepines; Catecholamines; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2012
Nicotine receptor partial agonists for smoking cessation. American family physician, 2011, Oct-01, Volume: 84, Issue:7 Topics: Adult; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2011
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Nov-15, Volume: 879, Issue:30 Topics: Benzazepines; Chromatography, High Pressure Liquid; Cotinine; Drug Stability; Humans; Linear Models; Nicotine; Quinoxalines; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Tandem Mass Spectrometry; Varenicline	2011
A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:17 Topics: Benzazepines; Cost-Benefit Analysis; Europe; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline	2011
Is varenicline effectiveness declining in randomized trials? Archives of internal medicine, 2011, Oct-24, Volume: 171, Issue:19 Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome	2011
Suicidal behavior and depression in smoking cessation treatments. PloS one, 2011, Volume: 6, Issue:11 Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline	2011
Effects of smoking cessation on central blood pressure and arterial stiffness. Vascular health and risk management, 2011, Volume: 7 Topics: Ankle Brachial Index; Benzazepines; Blood Pressure; Brachial Artery; Chi-Square Distribution; Compliance; Female; Humans; Japan; Male; Middle Aged; Nicotinic Agonists; Pulsatile Flow; Quinoxalines; Radial Artery; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Varenicline; Ventricular Function, Left	2011
The pain of giving up smoking. International journal of cardiology, 2012, Jan-26, Volume: 154, Issue:2 Topics: Benzazepines; Female; Humans; Inferior Wall Myocardial Infarction; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline	2012
More evidence that varenicline harms the heart. The Harvard mental health letter, 2011, Volume: 28, Issue:4 Topics: Benzazepines; Cardiovascular Diseases; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2011
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11. Addiction (Abingdon, England), 2012, Volume: 107, Issue:5 Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Health Behavior; Humans; Longitudinal Studies; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2012
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. Drug safety, 2012, Jan-01, Volume: 35, Issue:1 Topics: Adult; Aged; Benzazepines; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Varenicline	2012
Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder. Clinical schizophrenia & related psychoses, 2012, Volume: 5, Issue:4 Topics: Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Paranoid Personality Disorder; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline	2012
Real world evaluation of three models of NHS smoking cessation service in England. BMC research notes, 2012, Jan-06, Volume: 5 Topics: Adolescent; Adult; Benzazepines; Bupropion; Community Health Services; Counseling; England; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2012
New reports examine psychiatric risks of varenicline for smoking cessation. JAMA, 2012, Jan-11, Volume: 307, Issue:2 Topics: Benzazepines; Drug Labeling; Hospitalization; Humans; Nicotinic Agonists; Quinoxalines; Reproducibility of Results; Risk; Smoking Cessation; Suicidal Ideation; Suicide; Suicide, Attempted; United States; United States Food and Drug Administration; Varenicline	2012
Prescribing of nicotine replacement therapy to cardiovascular disease patients in England. Addiction (Abingdon, England), 2012, Volume: 107, Issue:7 Topics: Adult; Benzazepines; Bupropion; Coronary Disease; Drug Prescriptions; England; General Practice; Humans; Nicotinic Agonists; Prescription Drugs; Quinoxalines; Regression Analysis; Smoking Cessation; Smoking Prevention; Stroke; Tobacco Use Cessation Devices; Varenicline	2012
Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. European journal of clinical pharmacology, 2012, Volume: 68, Issue:7 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzazepines; Databases, Factual; Epistaxis; Female; Hemorrhage; Humans; Male; Middle Aged; Netherlands; New Zealand; Nicotinic Agonists; Pharmacovigilance; Quinoxalines; Smoking Cessation; Varenicline; Young Adult	2012
Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2012, Volume: 25, Issue:1 Topics: Adult; Benzazepines; Brain Injury, Chronic; Depression; Female; Humans; Male; Middle Aged; MMPI; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2012
Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:9 Topics: Adult; Aged; Benzazepines; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2012
Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:9 Topics: Adult; Attitude to Health; Benzazepines; Biomarkers; Black or African American; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult	2012
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. Hospital practice (1995), 2012, Volume: 40, Issue:1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. Hospital practice (1995), 2012, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Middle Aged; Nicaragua; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Stroke; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult	2012
Varenicline: aggression and homicidal ideation. Prescrire international, 2012, Volume: 21, Issue:124 Topics: Adult; Aggression; Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2012
Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats. Psychopharmacology, 2012, Volume: 223, Issue:1 Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Hypnotics and Sedatives; Infusions, Intravenous; Male; Metyrapone; Nicotine; Oxazepam; Quinoxalines; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Smoking Cessation; Varenicline	2012
The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:12 Topics: Benzazepines; Cardiovascular Diseases; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Varenicline	2012
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult	2013
Promoting smoking cessation. American family physician, 2012, Mar-15, Volume: 85, Issue:6 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Complementary Therapies; Family Practice; Female; Health Promotion; Humans; Male; Motivation; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline	2012
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2 Topics: Animals; Benzazepines; Corpus Striatum; Dopamine; Male; Nicotine; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Saimiri; Smoking Cessation; Synaptosomes; Varenicline	2012
Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein. The Journal of biological chemistry, 2012, Jul-06, Volume: 287, Issue:28 Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aplysia; Azocines; Benzazepines; Binding Sites; Binding, Competitive; Carrier Proteins; Cell Line; HEK293 Cells; Humans; Kinetics; Ligands; Models, Molecular; Mutation; Nicotine; Nicotinic Agonists; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2012
Drug-induced liver injury due to varenicline: a case report. BMC gastroenterology, 2012, Jun-08, Volume: 12 Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Benzazepines; Chemical and Drug Induced Liver Injury; Humans; International Normalized Ratio; Liver; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline; Withholding Treatment	2012
Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment. Healthcare quarterly (Toronto, Ont.), 2012, Volume: 15, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Benzazepines; Cost-Benefit Analysis; Drug Costs; Female; Humans; Insurance, Health, Reimbursement; Insurance, Pharmaceutical Services; Male; Middle Aged; Quinoxalines; Saskatchewan; Sex Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult	2012
Effectiveness of varenicline for smoking cessation at 2 urban academic health centers. European journal of internal medicine, 2012, Volume: 23, Issue:5 Topics: Academic Medical Centers; Adult; Benzazepines; Female; Hospitals, Urban; Humans; Male; Poisson Distribution; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2012
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System. Addiction (Abingdon, England), 2013, Volume: 108, Issue:1 Topics: Adult; Aged; Benzazepines; Bupropion; Female; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Military Personnel; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult	2013
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Clinical therapeutics, 2012, Volume: 34, Issue:8 Topics: Benzazepines; Bupropion; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Greece; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Models, Economic; Monte Carlo Method; Prevalence; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline	2012
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction (Abingdon, England), 2013, Volume: 108, Issue:1 Topics: Adolescent; Adult; Age Distribution; Aged; Australia; Benzazepines; Bupropion; Canada; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult	2013
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function. Toxicology and applied pharmacology, 2012, Nov-15, Volume: 265, Issue:1 Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline	2012
Adverse neuropsychiatric events associated with varenicline use in veterans: a case series. Issues in mental health nursing, 2012, Volume: 33, Issue:10 Topics: Adult; Benzazepines; Bipolar Disorder; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Stress Disorders, Post-Traumatic; Suicidal Ideation; Tobacco Use Disorder; United States; Varenicline; Veterans	2012
Alpha oscillations in response to affective and cigarette-related stimuli in smokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:5 Topics: Adult; Attention; Benzazepines; Brain; Bupropion; Cues; Demography; Electroencephalography Phase Synchronization; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Photic Stimulation; Quinoxalines; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Varenicline	2013
Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease. Current medicinal chemistry, 2012, Volume: 19, Issue:34 Topics: Benzazepines; Bupropion; Chromosomes, Human, Pair 15; Genetic Loci; Genome-Wide Association Study; Humans; Multigene Family; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Strategies to help a smoker who is struggling to quit. JAMA, 2012, Oct-17, Volume: 308, Issue:15 Topics: Behavior Therapy; Benzazepines; Bupropion; Chronic Disease; Counseling; Disease Management; Dopamine Uptake Inhibitors; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2012
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Brazil; Bupropion; Demography; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline	2013
[Methods and results of smoking cessation in cancer smoker's]. Bulletin du cancer, 2012, Volume: 99, Issue:11 Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2012
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study. BMJ (Clinical research ed.), 2012, Nov-08, Volume: 345 Topics: Acute Coronary Syndrome; Adult; Age Distribution; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Quinoxalines; Retrospective Studies; Risk Assessment; Sex Distribution; Smoking Cessation; Stroke; Survival Analysis; Varenicline	2012
Varenicline for smoking cessation. BMJ (Clinical research ed.), 2012, Nov-08, Volume: 345 Topics: Benzazepines; Cardiovascular Diseases; Drug Approval; Drug Monitoring; Female; Humans; Male; Needs Assessment; New Zealand; Nicotinic Agonists; Quinoxalines; Risk Assessment; Smoking Cessation; Suicidal Ideation; United States; United States Food and Drug Administration; Varenicline	2012
Tracking dental patient tobacco use and intervention in the academic clinical setting. Journal of dental education, 2012, Volume: 76, Issue:11 Topics: Age of Onset; Benzazepines; Bupropion; Counseling; Dental Records; Dopamine Uptake Inhibitors; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Medical History Taking; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Referral and Consultation; Schools, Dental; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Varenicline; West Virginia	2012
Smoking cessation interventions after acute coronary syndromes. Results of a cross-sectional survey in the Lazio Region of Italy. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2012, Volume: 78, Issue:2 Topics: Acute Coronary Syndrome; Benzazepines; Cross-Sectional Studies; Health Behavior; Health Care Surveys; Health Promotion; Humans; Italy; Nicotinic Agonists; Patient Discharge; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2012
Varenicline and bupropion: suicide. Prescrire international, 2012, Volume: 21, Issue:131 Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline	2012
Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey. Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:5 Topics: Adult; Alcohol Drinking; Benzazepines; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
[Consensus report for the clinical care of smoking cessation in Spain. Comité Nacional para la Prevención del Tabaquismo]. Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6 Topics: Benzazepines; Bupropion; Counseling; Humans; Motivation; Nicotinic Agonists; Patient Compliance; Patient Education as Topic; Persuasive Communication; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2013
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness. Drug and alcohol dependence, 2013, Sep-01, Volume: 132, Issue:1-2 Topics: Benzazepines; Cardiovascular Diseases; Comorbidity; Data Interpretation, Statistical; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Nicotinic Agonists; Opioid-Related Disorders; Prevalence; Primary Health Care; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline	2013
The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey. Pharmacoepidemiology and drug safety, 2013, Volume: 22, Issue:7 Topics: Adolescent; Adult; Aged; Benzazepines; Comprehension; Drug Labeling; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Patient Education as Topic; Patient Safety; Pharmacovigilance; Quinoxalines; Risk Assessment; Risk Factors; Risk Management; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult	2013
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10 Topics: Animals; Benzazepines; Cell Line; Cerebral Cortex; Humans; In Vitro Techniques; Nicotinic Agonists; Oocytes; Quinoxalines; Radioligand Assay; Rats; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus laevis	2005
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Benzazepines; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Minnesota; Nicotinic Agonists; Psychometrics; Quinoxalines; Reproducibility of Results; Severity of Illness Index; Sickness Impact Profile; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline	2005
[Medication for ending tobacco dependency. Current state]. Atencion primaria, 2005, Jun-30, Volume: 36, Issue:2 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline	2005
FDA speeds smoking cessation drug review. JAMA, 2006, Feb-08, Volume: 295, Issue:6 Topics: Benzazepines; Drug Approval; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2006
The neurobiological basis for partial agonist treatment of nicotine dependence. International journal of clinical practice, 2006, Volume: 60, Issue:5 Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2006
Molecule of the Month. Varenicline tartrate. Drug news & perspectives, 2006, Volume: 19, Issue:3 Topics: Benzazepines; Double-Blind Method; Drug Approval; Drugs, Investigational; Follow-Up Studies; Humans; Molecular Structure; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome; United States; United States Food and Drug Administration; Varenicline	2006
Varenicline for smoking cessation: definite promise, but no panacea. JAMA, 2006, Jul-05, Volume: 296, Issue:1 Topics: Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2006
Varenicline. Nature reviews. Drug discovery, 2006, Volume: 5, Issue:7 Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2006
Trials that matter: varenicline: a designer drug to help smokers quit. Annals of internal medicine, 2006, Nov-21, Volume: 145, Issue:10 Topics: Benzazepines; Designer Drugs; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline	2006
Efficacy of varenicline for smoking cessation. JAMA, 2006, Dec-06, Volume: 296, Issue:21 Topics: Benzazepines; Humans; Mental Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2006
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology, 2007, Volume: 52, Issue:3 Topics: Animals; Behavior, Animal; Benzazepines; Brain; Cell Line, Transformed; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; In Vitro Techniques; Male; Membrane Potentials; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Protein Binding; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self Administration; Smoking Cessation; Transfection; Varenicline	2007
Varenicline: new drug. Smoking cessation: no better than nicotine. Prescrire international, 2006, Volume: 15, Issue:86 Topics: Benzazepines; France; Humans; Nicotine; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; United States	2006
[Champix has become a registered drug]. Orvosi hetilap, 2007, Jan-28, Volume: 148, Issue:4 Topics: Benzazepines; Drug Approval; European Union; Humans; Hungary; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2007
Comment: Oral varenicline for smoking cessation. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:4 Topics: Benzazepines; Drug Administration Schedule; Humans; Quinoxalines; Smoking Cessation; Varenicline	2007
Varenicline (CHANTIX): a stop-smoking pill. ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses, 2006,Fall, Volume: 24, Issue:4 Topics: Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2006
[The path from cigarettes--with support it works better]. Medizinische Monatsschrift fur Pharmazeuten, 2007, Volume: 30, Issue:3 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2007
[Drug of the month. Varenicline (Champix)]. Revue medicale de Liege, 2007, Volume: 62, Issue:2 Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline	2007
Why choose varenicline (chantix) for smoking cessation treatment? Issues in mental health nursing, 2007, Volume: 28, Issue:6 Topics: Benzazepines; Choice Behavior; Counseling; Drug Monitoring; Humans; Patient Education as Topic; Patient Selection; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2007
[Giving up smoking is crucial for COPD patients]. MMW Fortschritte der Medizin, 2007, Feb-22, Volume: 149, Issue:8 Topics: Benzazepines; Bupropion; Family Practice; Humans; Patient Care Team; Patient Education as Topic; Physician-Patient Relations; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline	2007
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence. Nature clinical practice. Cardiovascular medicine, 2007, Volume: 4, Issue:9 Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
Smoking cessation update. South Dakota medicine : the journal of the South Dakota State Medical Association, 2007, Volume: 60, Issue:6 Topics: Adolescent; Adult; Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2007
How well does the new drug varenicline work for people who want to stop smoking? The Harvard mental health letter, 2007, Volume: 23, Issue:12 Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2007
Varenicline-induced manic episode in a patient with bipolar disorder. The American journal of psychiatry, 2007, Volume: 164, Issue:8 Topics: Benzazepines; Bipolar Disorder; Humans; Male; Middle Aged; Quinoxalines; Recurrence; Schizophrenic Psychology; Smoking Cessation; Varenicline	2007
Exacerbation of schizophrenia by varenicline. The American journal of psychiatry, 2007, Volume: 164, Issue:8 Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline	2007
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine. Pharmacotherapy, 2007, Volume: 27, Issue:10 Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Drug Combinations; Drug Interactions; Humans; Male; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2007
Smoking cessation: tactics that make a big difference. The Journal of family practice, 2007, Volume: 56, Issue:10 Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyline; Patient Education as Topic; Quinoxalines; Smoking Cessation; Social Support; Varenicline	2007
A new medication for the worst addiction. Current psychiatry reports, 2007, Volume: 9, Issue:5 Topics: Benzazepines; Bupropion; Drug Administration Schedule; Follow-Up Studies; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2007
A second varenicline trial. Current psychiatry reports, 2007, Volume: 9, Issue:5 Topics: Benzazepines; Bupropion; Delayed-Action Preparations; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2007
Varenicline as maintenance therapy. Current psychiatry reports, 2007, Volume: 9, Issue:5 Topics: Benzazepines; Double-Blind Method; Follow-Up Studies; Humans; Long-Term Care; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; Varenicline	2007
[Varenicline]. Revue de l'infirmiere, 2007, Issue:133 Topics: Benzazepines; Drug Monitoring; France; Humans; Nurse's Role; Patient Education as Topic; Patient Selection; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2007
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2008
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction (Abingdon, England), 2008, Volume: 103, Issue:1 Topics: Adult; Benzazepines; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; London; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline	2008
[New drugs; varenicline]. Nederlands tijdschrift voor geneeskunde, 2007, Nov-10, Volume: 151, Issue:45 Topics: Benzazepines; Humans; Nausea; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2007
[Varenicline--a new drug for smoking cessation]. Ugeskrift for laeger, 2007, Nov-19, Volume: 169, Issue:47 Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline	2007
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Current medical research and opinion, 2008, Volume: 24, Issue:2 Topics: Benzazepines; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Time Factors; Varenicline	2008
The truth about smoking cessation. The Johns Hopkins medical letter health after 50, 2007, Volume: 19, Issue:8 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline	2007
Varenicline: a new pharmaceutical approach to smoking cessation. Nursing for women's health, 2008, Volume: 12, Issue:1 Topics: Benzazepines; Controlled Clinical Trials as Topic; Health Knowledge, Attitudes, Practice; Humans; Nurse-Patient Relations; Nurse's Role; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; United States; Varenicline	2008
Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003. Respiratory medicine, 2008, Volume: 102, Issue:5 Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cost of Illness; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Econometric; Morbidity; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Sweden; Value of Life; Varenicline	2008
FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA, 2008, Mar-12, Volume: 299, Issue:10 Topics: Anticonvulsants; Benzazepines; Humans; Mental Disorders; Quinoxalines; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline	2008
Breaking away from a narrow prescribing protocol for medicinal nicotine. Addiction (Abingdon, England), 2008, Volume: 103, Issue:4 Topics: Administration, Cutaneous; Adult; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2008
Varenicline may trigger severe hypoglycaemia in Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:5 Topics: Benzazepines; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline	2008
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. The pharmacogenomics journal, 2008, Volume: 8, Issue:6 Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Genotype; Humans; Pharmacogenetics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline	2008
Drug addiction: a critical problem calling for novel solutions. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline	2008
Smoking cessation 2008. IDrugs : the investigational drugs journal, 2008, Volume: 11, Issue:4 Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline	2008
Varenicline: myocardial infarction: nicotine replacement is a better option. Prescrire international, 2008, Volume: 17, Issue:93 Topics: Benzazepines; Europe; Humans; Myocardial Infarction; Nicotine; Quinoxalines; Smoking Cessation	2008
The cost effectiveness of varenicline for smoking cessation. Managed care interface, 2007, Volume: 20, Issue:10 Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Surveys; Humans; Male; Medicaid; Middle Aged; Models, Econometric; Quinoxalines; Smoking Cessation; United States; Varenicline	2007
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. Neurobiology of learning and memory, 2008, Volume: 90, Issue:1 Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline	2008
Empowering dental hygienists: tobacco cessation resources. International journal of dental hygiene, 2008, Volume: 6, Issue:2 Topics: Benzazepines; Dental Hygienists; Humans; Mental Disorders; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline	2008
Varenicline for smoking cessation. Drug and therapeutics bulletin, 2008, Volume: 46, Issue:5 Topics: Adult; Benzazepines; Drug Costs; Humans; Meta-Analysis as Topic; Nicotinic Antagonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome; Varenicline	2008
Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation. Toxicologic pathology, 2008, Volume: 36, Issue:4 Topics: Adipose Tissue, Brown; Animals; Benzazepines; Dose-Response Relationship, Drug; Female; Lipoma; Male; Mediastinal Neoplasms; Nicotine; Nicotinic Agonists; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Sex Factors; Smoking Cessation; Varenicline	2008
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. PharmacoEconomics, 2008, Volume: 26, Issue:6 Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline	2008